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Global, regional, and national comparative risk assessment 
of 79 behavioural, environmental and occupational, and 
metabolic risks or clusters of risks in 188 countries, 
1990–2013: a systematic analysis for the Global Burden of 
Disease Study 2013
GBD 2013 Risk Factors Collaborators*
Summary
Background The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) is the ﬁ rst of a series of 
annual updates of the GBD. Risk factor quantiﬁ cation, particularly of modiﬁ able risk factors, can help to identify 
emerging threats to population health and opportunities for prevention. The GBD 2013 provides a timely opportunity 
to update the comparative risk assessment with new data for exposure, relative risks, and evidence on the appropriate 
counterfactual risk distribution.
Methods Attributable deaths, years of life lost, years lived with disability, and disability-adjusted life-years (DALYs) 
have been estimated for 79 risks or clusters of risks using the GBD 2010 methods. Risk–outcome pairs meeting 
explicit evidence criteria were assessed for 188 countries for the period 1990–2013 by age and sex using three inputs: 
risk exposure, relative risks, and the theoretical minimum risk exposure level (TMREL). Risks are organised into a 
hierarchy with blocks of behavioural, environmental and occupational, and metabolic risks at the ﬁ rst level of the 
hierarchy. The next level in the hierarchy includes nine clusters of related risks and two individual risks, with more 
detail provided at levels 3 and 4 of the hierarchy. Compared with GBD 2010, six new risk factors have been added: 
handwashing practices, occupational exposure to trichloroethylene, childhood wasting, childhood stunting, unsafe 
sex, and low glomerular ﬁ ltration rate. For most risks, data for exposure were synthesised with a Bayesian meta-
regression method, DisMod-MR 2.0, or spatial-temporal Gaussian process regression. Relative risks were based on 
meta-regressions of published cohort and intervention studies. Attributable burden for clusters of risks and all risks 
combined took into account evidence on the mediation of some risks such as high body-mass index (BMI) through 
other risks such as high systolic blood pressure and high cholesterol.
Findings All risks combined account for 57·2% (95% uncertainty interval [UI] 55·8–58·5) of deaths and 41·6% 
(40·1–43·0) of DALYs. Risks quantiﬁ ed account for 87·9% (86·5−89·3) of cardiovascular disease DALYs, ranging 
to a low of 0% for neonatal disorders and neglected tropical diseases and malaria. In terms of global DALYs in 
2013, six risks or clusters of risks each caused more than 5% of DALYs: dietary risks accounting for 11·3 million 
deaths and 241·4 million DALYs, high systolic blood pressure for 10·4 million deaths and 208·1 million DALYs, 
child and maternal malnutrition for 1·7 million deaths and 176·9 million DALYs, tobacco smoke for 6·1 million 
deaths and 143·5 million DALYs, air pollution for 5·5 million deaths and 141·5 million DALYs, and high BMI for 
4·4 million deaths and 134·0 million DALYs. Risk factor patterns vary across regions and countries and with time. 
In sub-Saharan Africa, the leading risk factors are child and maternal malnutrition, unsafe sex, and unsafe water, 
sanitation, and handwashing. In women, in nearly all countries in the Americas, north Africa, and the Middle 
East, and in many other high-income countries, high BMI is the leading risk factor, with high systolic blood 
pressure as the leading risk in most of Central and Eastern Europe and south and east Asia. For men, high systolic 
blood pressure or tobacco use are the leading risks in nearly all high-income countries, in north Africa and the 
Middle East, Europe, and Asia. For men and women, unsafe sex is the leading risk in a corridor from Kenya to 
South Africa.
Interpretation Behavioural, environmental and occupational, and metabolic risks can explain half of global mortality 
and more than one-third of global DALYs providing many opportunities for prevention. Of the larger risks, the 
attributable burden of high BMI has increased in the past 23 years. In view of the prominence of behavioural risk 
factors, behavioural and social science research on interventions for these risks should be strengthened. Many 
prevention and primary care policy options are available now to act on key risks.
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Introduction
The Global Burden of Disease, Injuries, and Risk Factor 
study 2013 (GBD 2013) is the ﬁ rst of a series of annual 
updates of the GBD. Quantiﬁ cation of functional health 
loss and mortality by disease and injury is an important 
input to more informed health policy, as is the 
contribution of diﬀ erent risk factors to patterns of disease 
and injury across countries. Risk factor quantiﬁ cation, 
particularly for modiﬁ able risk factors, can help to 
identify emerging threats to population health and 
opportunities for prevention.
The Global Burden of Disease study 2010 (GBD 2010) 
provided the most comprehensive comparative 
assessment of risk factors covering 67 risk factors or 
clusters of risks for 21 regions from 1990 to 2010.1 The 
GBD comparative risk assessment (CRA) brings together 
data for excess mortality and disability associated with 
risk factors, data for exposure to risks, and evidence-
based assumptions on the desired counterfactual 
distribution of risk exposure to estimate how much of 
the burden observed in a given year can be attributed to 
risk exposure in that year and in all previous years. 
GBD 2010 generated broad interest in the scientiﬁ c 
community and public health agencies.2–4 GBD 2010 also 
generated several scientiﬁ c debates on topics such as the 
magnitude of burden related to diet, the low estimates of 
burden related to unsafe water and sanitation, and 
exclusion of some risk–outcome pairs from the 
analysis.2,5–10 Additionally, new studies have been 
published since the release of GBD 2010 that inform 
both estimates of relative risks and exposure in diﬀ erent 
countries.11–15
The GBD 2013 provides a timely opportunity to 
update each aspect of the CRA with new data for 
exposure, add new risk–outcome pairs meeting study 
inclusion criteria, and incorporate new data for relative 
risks and the appropriate counterfactual risk 
distribution. Important insights from scientiﬁ c debates 
on GBD 2010 have been used in revised approaches. 
This analysis supersedes all previous GBD CRA results 
by providing a complete revised time-series of 
attributable burden from 1990 to 2013, for 188 countries, 
with consistent deﬁ nitions and methods. This CRA also 
allows us to explore how much of the burden of disease 
around the world is not explained by the behavioural, 
environmental and occupational, and metabolic risks 
included in this study.
Methods
Overview
In general, this analysis follows the CRA methods used 
in GBD 2010.1 Conceptually, the CRA approach evaluates 
how much of the burden of disease observed in a 
given year can be attributed to past exposure to a risk. 
Attributable burden is estimated by comparing observed 
health outcomes to those that would have been observed 
if a counterfactual level of exposure had occurred in the 
past. Given that diﬀ erent risks lead to diﬀ erent health 
Research in context
Evidence before this study
As part of the Global Burden of Disease (GBD) 2010 study a 
revision of the global comparative risk assessment was 
undertaken, with an expanded list of 67 risks and risk clusters 
by 21 world regions, and comparable estimates made for the 
time period 1990–2010. Quantiﬁ cation of the burden that can 
be attributed to risk factors is important information to set 
priorities in prevention.
Added value of this study
The GBD 2013 comparative risk assessment is a further update 
to the GBD 2010 study in several ways: (1) addition of new risk 
factors (handwashing practices, occupational exposure to 
trichloroethylene, childhood wasting, childhood stunting, 
unsafe sex, and low glomerular ﬁ ltration rate); (2) new data for 
exposure; (3) assumption of a lognormal rather than a normal 
distribution for most of the continuous risk factors to better 
represent the observed population distributions; (4) updates to 
the systematic reviews and meta-analyses of relative risks; 
(5) aggregation of the burden at multiple levels of risk factors, 
including the combined eﬀ ect of all GBD risk factors and 
aggregates of three large classes—ie, behavioural, 
environmental and occupational, and metabolic risk factors; 
(6) systematic inclusion of mediation between major risk 
factors in the quantiﬁ cation of the burden associated with joint 
risks; and (7) quantiﬁ cation of the risk burden for 188 countries. 
Furthermore, several major improvements to speciﬁ c risk 
factors were implemented, such as use of the latest analytical 
instruments for multilevel analysis of exposure (DisMod-MR), 
as well as production of burden estimates for 5-year intervals 
from 1990–2010 plus 2013.
Implications of all the available evidence
Comparative risk assessment enables policy makers to prioritise 
prevention by addressing the most important risk factors at the 
population level. The burden by aggregations of risk categories, 
such as air pollution or dietary risks, provides the broad view of 
investment priorities, whereras the size of burden for individual 
risks can inform the potential elements of a broader 
intervention package. In 2013, we explain 41% of burden by the 
79 GBD risk factors with a slight increase since 1990. This 
proportion varies between 28% and 61% between countries, 
highlighting the importance of making country estimates as 
the opportunities for intervention will vary accordingly. Unless 
new risk factors are identiﬁ ed, the proportion of burden that is 
not explained by GBD risk factors is likely to be less amenable to 
primary prevention but more of a concern for curative or 
rehabilitative services.
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outcomes, assessments are undertaken separately for 
speciﬁ c risk–outcome pairs.
For most risk–outcome pairs, we estimated the 
attributable burden using the following equations.
Where ABjasct is the attributable burden for risk factor j 
in age group a, sex s, country c and year t. DALYoasct is 
disability-adjusted life-years (DALYs) for cause o (of w 
relevant outcomes for risk factor j) in age group a, sex s, 
country c and year t. PAFjoasct is the population attributable 
fraction (PAF) for cause o due to risk factor j in age group 
a, sex s, country c and year t. Attributable deaths, years of 
life lost (YLLs), or years lived with disability (YLDs) are 
computed by substituting in the equation these metrics 
for DALYs.
Risks fall into three categories on the basis of how 
exposure is measured: dichotomous, polytomous, and 
continuous. High systolic blood pressure is an example 
of a risk measured on a continuous scale. The PAFjoasct for 
a continuous risk factor in each country is deﬁ ned as:16
RRjoasc (x) is the relative risk as a function of exposure 
level x for risk factor j, cause o, age-group a, sex s, and 
country c. l is the lowest level of exposure and u is the 
highest level of exposure observed. Pjasct (x) is the 
distribution of exposure for risk j in age-group a, sex s, 
country c, and year t. TMRELjas is the theoretical 
minimum risk exposure level for risk factor j, age group 
a, and sex s. The discrete version of this equation for 
polytomous and dichotomous risks is provided in the 
appendix (p 2).
The equations highlight the four key components by 
cause, age, sex, country, and year that go into estimations 
of the burden attributable to a risk factor: the number of 
deaths, YLLs, YLDs, or DALYs; exposure levels for a risk 
factor; relative risk of a given outcome due to exposure; 
and the counterfactual level of risk factor exposure. In 
the CRA approach, the counterfactual level of risk 
exposure is selected to be the risk exposure that is 
theoretically possible and minimises overall risk 
(theoretical minimum risk exposure level [TMREL]).17 
The intention is to quantify how much disease burden 
could be lowered by shifting the distribution of a risk to 
the level that would lead to the greatest improvement in 
population health. GBD 2013 provides the rates of 
mortality, YLLs, YLDs, and DALYs by cause.18,19 We focus 
here on the data and methods used to estimate 
79 behavioural, environmental and occupational, and 
metabolic risks and clusters of these risks, levels of 
exposure, relative risks, and the choice of TMREL (a 
more detailed presentation of methods is provided in 
appendix [pp 2–23]).
Risk–outcome pairs and risk factor hierarchy
In this analysis, we focus on three groups of risk factors: 
behavioural, environmental and occupational, and 
metabolic. Figure 1 shows a more complete causal web 
(not all the arrows detailing possible interconnections 
have been drawn) that recognises the role of four other 
sets of risks: genes; the microbiome and other host 
factors; public health and medical care interventions; 
and social, economic, and cultural factors. It is currently 
beyond the scope of this study to quantify these other 
categories of risks or causes; however, in future iterations 
of the GBD we intend to broaden the analysis to include 
at least some of these broader causes.
For the current assessment focused on behavioural, 
environmental and occupational, and metabolic risk 
factors, risk–outcome pairs have been included based on 
four criteria. These criteria take into account the 
importance of each risk factor to either disease burden, 
policy, or both; the availability of suﬃ  cient data to 
estimate risk factor exposure; evidence from 
epidemiological studies supporting a causal relation 
between risk factor exposure and the outcome and 
available data to estimate eﬀ ect sizes per unit of exposure 
increase; and evidence that these eﬀ ects can be applied to 
a general population. Following GBD 2010, we have 
adopted the World Cancer Research Fund grading of 
evidence supporting the causal relation between risk 
factor exposure and an outcome. They deﬁ ned four levels 
of evidence: convincing, probable, possible, and 
insuﬃ  cient. Only risk–outcome pairs judged to meet the 
criteria of convincing or probable were included. 
Convincing evidence is deﬁ ned as “evidence based on 
epidemiological studies showing consistent associations 
between exposure and disease, with little or no evidence 
to the contrary. The available evidence is based on a 
substantial number of studies including prospective 
observational studies and where relevant, randomised 
controlled trials of suﬃ  cient size, duration, and quality 
showing consistent eﬀ ects. The association should be 
biologically plausible.” Probable evidence is deﬁ ned as 
“evidence based on epidemiological studies showing 
ABjasct = DALYoasct PAFjoasctΣ
w
1
PAFjoasct =
 RRjoasc (x) Pjasct (x) dx – RRjoasc (TMRELjas) ∫ 
u 
x = l 
 RRjoasc (x) Pjasct (x) dx∫ 
u 
x = l 
See Online for appendix
Figure 1: A more general causal web of the causes of health outcomes
Categories of causes included in this analysis shown in blue. GBD=Global Burden of Disease.
Social
Cultural
Economic
Microbiome
and host
Health
intervention
Pathogens
Environmental
or occupational
Genes Morbidity
Mortality
MetabolicBehaviours
 Currently 
 included in GBD
 Not currently
 included in GBD
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Exposure deﬁ nition Theoretical minimum risk exposure 
level
Data representativeness index
<1998 1998–2005 2006–13 Total
All risk factors ·· ·· 100·0% 100·0% 100·0% 100·0%
Environmental and 
occupational risks
·· ·· 100·0% 100·0% 100·0% 100·0%
Unsafe water, sanitation, 
and handwashing
59·0% 72·3% 60·6% 80·3%
Unsafe water source Proportion of households with access to diﬀ erent water 
sources (unimproved, improved except piped, piped water 
supply) and reported use of household water treatment 
methods (boiling or ﬁ ltering; chlorinating or solar ﬁ ltering; no 
treatment)
All households have access to water 
from a piped water supply that is also 
boiled or ﬁ ltered before drinking
69·6% 84·2% 68·4% 91·8%
Unsafe sanitation Proportion of households with access to diﬀ erent sanitation 
facilities (unimproved, improved except sewer, sewer 
connection)
All households have access to toilets 
with sewer connection
65·8% 81·6% 67·1% 91·1%
No handwashing with 
soap
Proportion of individuals who wash their hands with soap and 
water after potential faecal contact
All individuals wash hands with soap 
and water after potential faecal contact
1·1% 10·1% 25·5% 29·3%
Air pollution 100·0% 100·0% 100·0% 100·0%
Ambient particulate 
matter pollution
Annual average daily exposure to outdoor air concentrations 
of particulate matter (PM) with an aerodynamic diameter 
smaller than 2·5 μm, measured in μg/m³
Uniform distribution between 
5·9 μg/m3 and 8·7 μg/m³
99·5% 99·5% 99·5% 99·5%
Household air pollution 
from solid fuels
Annual average daily exposure to household concentrations of 
particulate matter (PM) with an aerodynamic diameter smaller 
than 2·5 μm, measured in μg/m³ from solid fuel use (coal, 
wood, charcoal, dung, and agricultural residues)
No households are exposed to excess 
indoor concentration of particles from 
solid fuel use (assuming concentration 
of particulate matters, aerodynamic 
diameter smaller than 2·5 μg/m3, 
measured in μg/m3 in no fuel use is 
consistent with a TMREL of 5·9–8·7)
47·8% 83·3% 71·7% 94·2%
Ambient ozone pollution Seasonal (3 month) hourly maximum ozone concentrations, 
measured in parts per billion (ppb)
Uniform distribution between 
33·3 μg/m³ and 41·9 μg/m³, according to 
minimum/5th percentile concentrations
100·0% 100·0% 100·0% 100·0%
Other environmental risks 34·0% 38·8% 26·6% 49·5%
Residential radon Average daily exposure to indoor air radon levels measured in 
becquerels (radon disintegrations per s) per cubic metre 
(Bq/m³)
10 Bq/m³, corresponding to the outdoor 
concentration of radon
19·7% 27·1% 11·7% 38·3%
Lead exposure Blood lead levels in μg/dL of blood, bone lead levels in μg/g of 
bone
2 μg/dL, corresponding to lead levels in 
pre-industrial humans as natural 
sources of lead prevent the feasibility of 
zero exposure
29·3% 27·1% 20·2% 39·9%
Occupational risks 56·4% 64·4% 55·3% 72·3%
Occupational carcinogens ·· ·· 34·0% 56·9% 51·6% 62·8%
Occupational exposure 
to asbestos
Proportion of the population with cumulative exposure to 
asbestos
No occupational exposure to asbestos ·· ·· ·· ··
Occupational exposure 
to arsenic
Proportion of the population ever exposed to arsenic at work/
through their occupation
No occupational exposure to arsenic ·· ·· ·· ··
Occupational exposure 
to benzene
Proportion of the population ever exposed to benzene at 
work/through their occupation
No occupational exposure to benzene ·· ·· ·· ··
Occupational exposure 
to beryllium
Proportion of the population ever exposed to beryllium at 
work/through their occupation
No occupational exposure to beryllium ·· ·· ·· ··
Occupational exposure 
to cadmium
Proportion of the population ever exposed to cadmium at 
work/through their occupation
No occupational exposure to cadmium ·· ·· ·· ··
Occupational exposure 
to chromium
Proportion of the population ever exposed to chromium at 
work/through their occupation
No occupational exposure to chromium ·· ·· ·· ··
Occupational exposure 
to diesel engine exhaust
Proportion of the population ever exposed to diesel engine 
exhaust at work/through their occupation
No occupational exposure to diesel 
engine exhaust
·· ·· ·· ··
Occupational exposure 
to second-hand smoke
Proportion of the population ever exposed to second-hand 
smoke at work/through their occupation
No occupational exposure to 
second-hand smoke
·· ·· ·· ··
Occupational exposure 
to formaldehyde
Proportion of the population ever exposed to formaldehyde at 
work/through their occupation
No occupational exposure to 
formaldehyde
·· ·· ·· ··
Occupational exposure 
to nickel
Proportion of the population ever exposed to nickel at work/
through their occupation
No occupational exposure to nickel ·· ·· ·· ··
(Table 1 continues on next page)
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Exposure deﬁ nition Theoretical minimum risk exposure 
level
Data representativeness index
<1998 1998–2005 2006–13 Total
(Continued from previous page)
Occupational exposure 
to polycyclic aromatic 
hydrocarbons
Proportion of the population ever exposed to polycyclic 
aromatic hydrocarbons at work/through their occupation
No occupational exposure to polycyclic 
aromatic hydrocarbons
·· ·· ·· ··
Occupational exposure 
to silica
Proportion of the population ever exposed to silica at work/
through their occupation
No occupational exposure to silica ·· ·· ·· ··
Occupational exposure 
to sulphuric acid
Proportion of the population ever exposed to sulphuric acid at 
work/through their occupation
No occupational exposure to sulphuric 
acid
·· ·· ·· ··
Occupational exposure 
to trichloroethylene
Proportion of the population ever exposed to 
trichloroethylene at work/through their occupation
No occupational exposure to 
trichloroethylene
·· ·· ·· ··
Occupational asthmagens Proportion of the population currently exposed to 
asthmagens at work/through their occupation
Background asthmagen exposures 41·0% 37·2% 36·2% 52·7%
Occupational particulate 
matter, gases, and fumes
Proportion of the population ever exposed to particulates, 
gases, or fumes at work/through their occupation
No occupational exposure to 
particulates, gases, or fumes
34·0% 56·9% 51·6% 62·8%
Occupational noise Proportion of the population ever exposed to noise greater 
than 85 decibels at work/through their occupation Background noise exposure
34·0% 56·9% 51·6% 62·8%
Occupational injuries Proportion of the population at risk to injuries related to work/
through their occupation
The rate of injury deaths per 
100 000 person-years is zero
5·3% 17·0% 18·6% 20·7%
Occupational ergonomic 
factors
Proportion of the population who are exposed to ergonomic 
risk factors for low back pain at work/through their occupation
All individuals have the ergonomic 
factors of clerical and related workers
32·4% 58·5% 48·9% 63·3%
Behavioural risks ·· ·· 100·0% 100·0% 100·0% 100·0%
Child and maternal 
malnutrition
97·3% 97·9% 96·8% 98·9%
Suboptimal breastfeeding 44·7% 68·1% 55·9% 78·2%
Non-exclusive 
breastfeeding
Proportion of children younger than 6 months who receive 
predominant, partial, or no breastfeeding
All children are exclusively breastfed for 
ﬁ rst 6 months of life
·· ·· ·· ··
Discontinued 
breastfeeding
Proportion of children aged 6–23 months who do not receive 
any breastmilk
All children continue to receive breast 
milk until 2 years of age
·· ·· ·· ··
Childhood undernutrition 79·3% 72·3% 59·6% 86·7%
Childhood underweight Proportion of children less than –3 SDs, –3 to
–2 SDs, and –2 to –1 SDs of the WHO 2006 standard weight-
for-age curve
All children are above –1 SD of the 
WHO 2006 standard weight-for-age 
curve
·· ·· ·· ··
Childhood wasting Proportion of children less than –3 SDs, –3 to
–2 SDs, and –2 to –1 SDs of the WHO 2006 standard weight-
for-length curve
All children are above –1 SD of the 
WHO 2006 standard weight-for-height 
curve
·· ·· ·· ··
Childhood stunting Proportion of children less than –3 SDs, –3 to
–2 SDs, and –2 to –1 SDs of the WHO 2006 standard height-
for-age curve
All children are above –1 SD of the 
WHO 2006 standard height-for-height 
curve
·· ·· ·· ··
Iron deﬁ ciency Peripheral blood haemoglobin concentration in g/L Country speciﬁ c 40·4% 34·0% 22·3% 45·7%
Vitamin A deﬁ ciency Proportion of children aged 28 days to 5 years with serum 
retinol concentration <0·7 μmol/L
No childhood vitamin A deﬁ ciency 22·9% 53·7% 45·7% 58·5%
Zinc deﬁ ciency Proportion of the population with inadequate zinc intake 
versus loss
No inadequate zinc intake 89·9% 89·9% 91·0% 91·0%
Tobacco smoke 34·0% 91·0% 95·7% 98·4%
Smoking Proportion of the population with cumulative exposure to 
tobacco smoking; proportion of the population who 
currently smoke
100% of population is lifelong non-
smokers
34·0% 89·4% 93·6% 96·3%
Second-hand smoke Average daily exposure to indoor air particulate matter from 
second-hand smoke with an aerodynamic diameter smaller 
than 2·5 μg, measured in μg/m3
No second-hand smoke exposure 8·5% 69·1% 87·2% 92·6%
Alcohol and drug use 100·0% 100·0% 100·0% 100·0%
Alcohol use Average daily alcohol consumption of pure alcohol 
(measured in g/day) in current drinkers who had consumed 
alcohol during the past 12 months; binge drinking deﬁ ned as 
proportion of the population reporting binge consumption 
of at least 60 g for males and 48 g for females of pure 
alcohol on a single occasion
No alcohol consumption 100·0% 100·0% 100·0% 100·0%
(Table 1 continues on next page)
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Exposure deﬁ nition Theoretical minimum risk exposure 
level
Data representativeness index
<1998 1998–2005 2006–13 Total
(Continued from previous page)
Drug use Proportion of the population dependent on opioids, 
cannabis, cocaine, or amphetamines; proportion of the 
population who have ever injected drugs
No use 28·7% 50·5% 54·3% 67·0%
Dietary risks 89·9% 93·1% 92·0% 94·1%
Diet low in fruits Average daily consumption of fruits (fresh, frozen, cooked, 
canned, or dried, excluding fruit juices and salted or pickled 
fruits)
Consumption of fruit between 200 g 
and 400 g per day
19·1% 38·8% 22·9% 56·4%
Diet low in vegetables Average daily consumption of vegetables (fresh, frozen, 
cooked, canned, or dried vegetables, including legumes but 
excluding salted or pickled vegetables, juices, nuts and seeds, 
and starchy vegetables such as potatoes or corn)
Consumption of vegetables between 
350 g and 450 g per day
88·8% 92·6% 90·4% 93·6%
Diet low in whole grains Average daily consumption of whole grains (bran, germ, and 
endosperm in their natural proportion) from breakfast 
cereals, bread, rice, pasta, biscuits, muﬃ  ns, tortillas, 
pancakes, and other sources
Consumption of whole grains between 
100 g and 150 g per day
87·8% 89·9% 89·4% 89·9%
Diet low in nuts and seeds Average daily consumption of nut and seed foods Consumption of nuts and seeds 
between 12 g and 20 g per day
78·7% 85·1% 83·0% 86·7%
Diet low in milk Average daily consumption of milk, including non-fat, low-
fat, and full-fat milk, excluding soy milk and other plant 
derivatives
Consumption of milk between 425 g 
and 475 g per day
88·8% 91·0% 89·4% 91·0%
Diet high in red meat Average daily consumption of red meat (beef, pork, lamb, 
and, goat but excluding poultry, ﬁ sh, eggs, and all processed 
meats)
Consumption of red meat between 
11·4 g and 17·1 g per day
88·8% 91·0% 89·4% 91·0%
Diet high in processed 
meat
Average daily consumption of meat preserved by smoking, 
curing, salting, or addition of chemical preservatives
Consumption of processed meat 
between 0 g and 14·3 g per day
14·4% 24·5% 6·9% 28·2%
Diet high in sugar-
sweetened beverages
Average daily consumption of beverages with ≥50 kcal per 
226·8 g serving, including carbonated beverages, sodas, 
energy drinks, and fruit drinks, but excluding 100% fruit and 
vegetable juices
Consumption of sugar-sweetened 
beverages between 0 g and 64·3 g 
per day
13·8% 23·9% 7·4% 27·1%
Diet low in ﬁ bre Average daily intake of ﬁ bre from all sources including fruits, 
vegetables, grains, legumes, and pulses
Consumption of ﬁ bre between 28 g 
and 32 g per day
12·8% 19·7% 9·0% 27·1%
Diet suboptimal in calcium Average daily intake of calcium from all sources, including 
milk, yogurt, and cheese
Consumption of calcium between 0 g 
and 0·77 g per day
15·4% 20·7% 11·2% 31·4%
Diet low in seafood 
omega-3 fatty
acids
Average daily intake of eicosapentaenoic acid and 
docosahexaenoic acid
Consumption of seafood omega-3 
fatty acids between 200 mg and 
300 mg per day
87·7% 90·4% 88·8% 90·4%
Diet low in 
polyunsaturated fatty 
acids
Average daily intake of omega-6 fatty acids from all sources, 
mainly liquid vegetable oils, including soybean oil, corn oil, 
and saﬄ  ower oil
Consumption of polyunsaturated fatty 
acids between 10% and 15% of total 
daily energy
9·0% 12·2% 5·3% 17·0%
Diet high in trans fatty 
acids
Average daily intake of trans fat from all sources, mainly 
partially hydrogenated vegetable oils and ruminant 
products
Consumption of trans fatty acids 
between 0% and 0·8% of total daily 
energy
8·5% 42·0% 42·0% 42·0%
Diet high in sodium 24 h urinary sodium measured in mg per day Consumption of sodium between 1 g 
and 5 g per day
25·0% 18·6% 11·7% 33·5%
Sexual abuse and violence 17·6% 45·7% 53·2% 66·0%
Childhood sexual abuse Proportion of the population who have ever experienced 
one or more acts of childhood sexual abuse, deﬁ ned as the 
experience with an older person of unwanted non-contact, 
contact abuse, or intercourse, when aged 15 years or 
younger
No childhood sexual abuse 9·0% 25·5% 17·6% 37·8%
Intimate partner violence Proportion of the population who have ever experienced 
one or more acts of physical or sexual violence by a present 
or former intimate partner since age 15 years
No intimate partner violence 13·8% 44·1% 47·3% 61·7%
Unsafe sex Proportion of the population with exposure to sexual 
encounters that convey the risk of disease
No exposure to a disease agent 
through sex
14·4% 17·0% 43·1% 43·6%
Low physical activity Average weekly physical activity at work, home, 
transport-related, and recreational measured by 
metabolic equivalent (MET) mins per week
Highly active, ≥8000 MET min 
per week
0·0% 50·5% 31·4% 63·3%
(Table 1 continues on next page)
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fairly consistent associations between exposure and 
disease, but for which there are perceived shortcomings 
in the available evidence or some evidence to the contrary, 
which precludes a more deﬁ nite judgment. Shortcomings 
in the evidence may be any of the following: insuﬃ  cient 
duration of trials (or studies); insuﬃ  cient trials (or 
studies) available; inadequate sample sizes; or incomplete 
follow-up. Laboratory evidence is usually supportive. The 
association should be biologically plausible.”
Table 1 summarises the included risk factors; there are, 
counting risks and clusters of risks, 79 diﬀ erent risks in 
the hierarchy, including 13 level 2 groupings of risk 
factors and 63 individual risks. We have quantiﬁ ed the 
burden of each of the level 1, level 2, and level 3 groupings 
and an overall estimate of all risk factors combined. 
Risks are organised into a hierarchy with blocks of 
behavioural, environmental and occupational, and 
metabolic risks at the ﬁ rst level of the hierarchy. The next 
level in the hierarchy includes nine clusters of related 
risks and two individual risks, with more detail provided 
at levels 3 and 4 of the hierarchy. New risk–outcome pairs 
were added for risks already included in GBD 2010 due to 
new evidence, and some risk–outcome pairs were 
excluded because they did not meet the quality of 
evidence criteria.
Estimating risk factor exposure
Data and exposure categories
For each risk factor exposure, we began with the 
GBD 2010 sources and supplemented those by identifying 
and using published studies through systematic reviews 
of the literature, household survey data, census data, and 
satellite data (used for PM2·5 estimation). Our analyses 
for the GBD 2013 of tobacco smoking prevalence and 
obesity have been published.20,21 For some risks such as 
diet and alcohol consumption, we have also used 
administrative record systems. Appendix pp 88–475 
provides citations for all sources used for estimating risk 
factor exposure organised by country.
We have computed a data representativeness index 
(DRI) for risk factor exposure estimation. The DRI for a 
risk factor is the fraction of countries for which we have 
identiﬁ ed any data for the risk factor. Table 1 also provides 
the DRI for the entire period 1985–2013 and the DRI 
calculated for three intervals: pre-1997, 1998–2005, and 
from 2006 to 2013. The overall DRI ranges from 17% for 
diet low in polyunsaturated fatty acids to 100% for 
ambient ozone pollution and ambient particulate matter 
pollution. The DRI for PM2·5 is 100% because data are 
available for all countries and all years, although direct 
satellite observations are unavailable before 1998.
Modelling strategies for exposure levels
Appendix pp 49–51 lists the modelling strategy used to 
estimate exposure for every risk factor. For 23 risks, we 
used DisMod-MR 2.0, which is a Bayesian meta-
regression method used extensively in estimating the 
prevalence of diseases for GBD 2013. See Vos and 
colleagues19 for a detailed description of the likelihood 
used for estimation and an explanation of improvements 
in DisMod-MR 2.0 compared with DisMod-MR 1.0, used 
in GBD 2010. In brief, DisMod-MR 2.0 shows 
improvements over DisMod-MR 1.0 in computational 
speed, geographical disaggregation, and display 
capabilities. The advantage of DisMod-MR 2.0 is that it 
estimates both the age–sex pattern of a risk as well as 
diﬀ erent levels over time based on estimation for 1990, 
1995, 2000, 2005, 2010, and 2013. For 12 risk factors 
modelled with DisMod-MR 2.0, we conducted cross-
validation tests (appendix pp 476–78).
For 34 risks, we used spatiotemporal Gaussian process 
regression (ST-GPR), which was also used for multiple 
risk factors in GBD 2010.21 ST-GPR has been used for risk 
factors for which the data density is suﬃ  cient to estimate 
a very ﬂ exible time trend that does not vary over age. If 
the tabulated data were in standard age groups or at the 
household level, such as access to diﬀ erent levels of 
improved water and sanitation, exposure to radon, or 
Exposure deﬁ nition Theoretical minimum risk exposure 
level
Data representativeness index
<1998 1998–2005 2006–13 Total
(Continued from previous page)
Metabolic risks ·· ·· 68·1% 89·9% 87·8% 97·9%
High fasting plasma glucose Serum fasting plasma glucose, measured in mmol/L 4·8–5·4 31·4% 38·3% 23·4% 54·3%
High total cholesterol Serum total cholesterol, measured in mmol/L 3·0–4·8 23·9% 27·7% 22·3% 46·8%
High systolic blood pressure Systolic blood pressure, measured in mm Hg 107–119 36·2% 45·7% 36·2% 71·8%
High body-mass index Body-mass index, measured in kg/m² 21–23 57·4% 87·8% 86·2% 97·3%
Low bone mineral density Standardised mean bone mineral density values measured 
at the femoral neck in g/cm²
99th percentile of NHANES 2005–10 
by age and sex
14·9% 19·7% 6·9% 25·5%
Low glomerular ﬁ ltration 
rate
Proportion of the population with a GFR <60 mL per min 
per 1·73 m², and excluding end-stage renal disease
>60 mL per min per 1·73 m² 5·3% 12·2% 14·4% 21·8%
Table 1: GBD 2013 risk factor hierarchy, exposure deﬁ nitions, theoretical minimum risk exposure level, and data representativeness index (DRI) for the entire period 1985–2013, 
pre-1998, 1998–2005, and 2006–13 
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available zinc intake, we used ST-GPR; but if the data 
were available by diﬀ erent age intervals or mixed sex 
groups, we used DisMod-MR 2.0 because of its ability to 
integrate over age and adjust for diﬀ erent exposure 
deﬁ nitions in the data.
For PM2·5, estimates of annual concentrations were 
generated by combining data from atmospheric chemistry 
transport models and satellite retrievals of aerosols in the 
atmosphere.22 The combined PM2·5 concentrations were 
then calibrated against observations from ground-level 
monitoring of particles from more than 75 countries. For 
modelling the burden attributable to tobacco smoking, 
we used the smoking impact ratio (SIR) developed by 
Peto, Lopez, and colleagues23 for cancers and chronic 
respiratory disease, and 5-year lagged smoking prevalence 
for all cardiovascular outcomes, tuberculosis, diabetes, 
and asthma. The SIR is used to reﬂ ect past exposure, 
duration, and intensity of smoking in a population.23 
Alcohol exposure estimation used both administrative 
and survey data to estimate levels of abstainers, former 
drinkers, binge drinkers, and drinks per day for regular 
drinkers. Physical activity exposure was modelled in 
terms of four categories of metabolic equivalent (MET) 
min per week (ratio of metabolic rate during a speciﬁ c 
physical activity to a resting metabolic rate): inactivity, less 
than 600 MET min per week; low activity, 600–3999; 
moderate activity, 4000–7999; and high activity, greater 
than 8000. Exposure to occupational risks was estimated 
with data from labour force surveys and censuses on the 
economically active population available from the 
International Labour Organization (ILO; Geneva, 
Switzerland). The distribution of the economically active 
population across nine industries or eight occupational 
groups was used to measure exposure to occupational 
asthmagens, particulate matter, noise, and ergonomic 
factors.
To calculate the burden of every continuous risk factor, 
the distribution of exposure needs to be estimated, which 
includes central tendency and dispersion parameters. We 
modelled mean and SD because these can be derived 
from nearly all published studies. In GBD 2010, for 
computational simplicity, all continuous risks were 
assumed to be normally distributed, so mean and SD 
were used to simulate the population distribution in the 
PAF calculation. Considerable evidence suggests that 
most risks are not normally distributed, so we have 
devoted substantial eﬀ ort to choosing appropriate 
distribution for each risk factor.24–27 First, we modelled the 
natural log of the SD using observed data as a function of 
the mean and ﬁ xed eﬀ ects on risk and super-region. 
Second, we evaluated the likelihood value of ﬁ tting 
normal, lognormal, gamma, beta, and inverse Gaussian 
distributions to the US National Health and Nutrition 
Examination Survey (NHANES) micro-data for systolic 
blood pressure, body-mass index (BMI), fasting plasma 
glucose, and cholesterol. We found that the lognormal 
distribution ﬁ t the available data best for all but three risk 
factors. For iron deﬁ ciency and low bone mineral density, 
the normal distribution had the best ﬁ t. For high BMI, 
we used a beta distribution for which BMI is ﬁ rst 
transformed to be on a 0 to 1 scale, and the α and beta 
parameters for the distribution are ﬁ t to the mean and 
SD with the constraint that skewness cannot be negative.
Relative risks for systolic blood pressure have been 
corrected for regression dilution bias.28 To be consistent 
with the adjusted relative risks for regression dilution 
bias, we have corrected exposure SDs for a measure of 
intertemporal variance in blood pressure observed in 
cohort studies; this eﬀ ectively ensures that our values 
reﬂ ect usual systolic blood pressure.
Estimating the eﬀ ects of risk factors on disease and 
injury outcomes
For 59 component risk factors, for which we estimate 
attributable burden using the relative risk and exposure 
formula, we estimated relative risks of mortality and 
morbidity based on either published meta-analyses, 
meta-analyses updated with new studies, or new meta-
regressions that include covariates such as age, sex, or 
country-level predictors for the GBD 2013.
For every risk factor, relevant outcomes meeting the 
World Cancer Research Fund criteria of convincing or 
probable evidence for a causal association were identiﬁ ed. 
We used almost all outcomes from GBD 2010 and added 
35 new outcomes (appendix p 10) to them through a 
comprehensive review of the list. For risk–outcome pairs 
for which evidence is only available on either mortality or 
morbidity, we assumed that the estimated relative risks 
applied equally to both. Where there was evidence of 
statistically diﬀ erent relative risks for mortality and 
morbidity, we used diﬀ erent relative risks for each. 
Of note, relative risks were not consistently higher 
or lower for mortality compared with morbidity. 
Appendix pp 479–614 summarise the relative risks used 
by age and sex for each risk factor and outcome pair, and 
appendix pp 615–709 provide citations for all sources 
used for relative risks. We used relative risks from studies 
controlled for confounding but not controlling for factors 
along the causal pathway between exposure and outcome.
We used an updated meta-regression for water, 
sanitation, and handwashing with results from recently 
published studies.11,12 We conducted a new meta-regression 
for physical activity by converting the activity levels for 
which relative risk data are available to total MET mins of 
activity per week. DisMod-MR 2.0 was used to generate a 
continuous risk curve for every outcome as a function of 
MET mins activity per week. We updated the relative risks 
for childhood underweight, stunting, and wasting using a 
recently published study that did a pooled analysis of 
children enrolled in ten prospective cohorts in Africa, 
Asia, and South America.29,30 The updated relative risks 
for all three anthropometric indicators showed that they 
have no signiﬁ cant eﬀ ect on malaria. Finally, we assumed 
that 100% of the burden of protein-energy malnutrition 
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was attributable to childhood underweight and wasting. 
The integrated exposure–response curve was used as a 
framework for ambient particulate matter pollution, 
household air pollution, secondhand smoke, and tobacco 
smoking in GBD 2010.31 For GBD 2013, we re-estimated 
these relations with recently published studies of relative 
risk and also extended their use to estimate the burden 
from secondhand smoke and household air pollution for 
chronic obstructive pulmonary disease.31–39
In some cases, evidence of the direct relation between a 
risk factor and a disease outcome was lacking or extremely 
sparse. For three risk factors (lead, sugar-sweetened 
beverages, and sodium), we estimated relative risks 
through a two-stage process.40–42 For sodium and disease 
outcomes other than gastric cancer, we ﬁ rst estimated the 
relation between 24-h sodium excretion and change in 
systolic blood pressure. Second, we estimated the relation 
between change in blood pressure and disease outcomes 
to estimate the eﬀ ect of sodium on outcomes. This two-
stage approach was also used for chronic lead exposure 
on adults (eﬀ ect of bone lead through blood pressure) and 
sugar-sweetened beverages (through BMI).
Alcohol and high BMI are the only risk factors included 
in our current analysis that show a signiﬁ cant protective 
eﬀ ect for selected outcomes, and the protective eﬀ ects are 
restricted to certain groups (ie, premenopausal women 
for high BMI) or levels of intake (ie, alcohol).43,44 Recent 
studies conﬁ rmed previous meta-analyses that indicated 
a protective eﬀ ect of high BMI on breast cancer in 
premenopausal women outside Asia–Paciﬁ c countries.45,46 
These protective eﬀ ects were estimated and included as 
negative attributable burden in our calculations.
Theoretical minimum risk exposure level (TMREL)
In the CRA framework, attributable burden is calculated 
with respect to a counterfactual risk exposure (see 
equation 2). In GBD 2010, we used the exposure 
distribution that minimises risk for the population, 
termed the theoretical minimum risk exposure 
distribution (TMRED).17 Based on a consultation with 
risk factor epidemiologists, we have chosen to simplify 
the TMRED and to choose a single level of risk exposure 
that minimises risk from all causes of DALYs combined, 
which we term the theoretical minimum risk exposure 
level (TMREL). The TMREL by its deﬁ nition should 
Figure 2: Tree maps of global deaths (A) and global DALYs (B) for GBD level 2 
causes for all ages, both sexes combined in 2013
The fraction of each cause attributable to all risk factors combined is shown with 
dark shading. DALYs=disability-adjusted life-years. GBD=Global Burden of Disease. 
Chr Resp=chronic respiratory diseases. Diab + Urog + Haem=diabetes, urogenital, 
blood, and endocrine diseases. Diar + LRI + Oth=diarrhoea, lower respiratory, and 
other common infectious diseases. HIV + TB=HIV/AIDS and tuberculosis. 
Mental=mental and substance use disorders. MSK=musculoskeletal disorders. 
Neuro=neurological disorders. Nutr Def=nutritional deﬁ ciencies. Oth NCD=other 
non-communicable diseases. Other group I=other communicable, maternal, 
neonatal, and nutritional diseases. NTD + Malaria=neglected tropical diseases and 
malaria. Self-harm + IPV=self-harm and interpersonal violence. Trans 
Inj=transportation injuries. Unint Inj=unintentional injuries.
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minimise individual (and population level) risk and be 
theoretically possible to achieve, but not necessarily 
aﬀ ordable or feasible to achieve. Table 1 shows the 
TMREL for each risk factor. In some cases, such as 
sodium consumption, the evidence supporting the 
selection of the TMREL is uncertain. In these cases, we 
include in the uncertainty estimation sampling a 
uniform distribution of diﬀ erent TMRELs.
As part of GBD 2013, we have modiﬁ ed the TMREL to 
be households with piped water connections and those 
who also boil or ﬁ lter their water before drinking for 
unsafe water. Similarly, the TMREL for unsafe sanitation 
is now deﬁ ned by the proportion of households that have 
access to sewer-connected toilet facilities.
In GBD 2010, a TMRED with a mean of 1 g per day of 
urinary sodium excretion was used for sodium intake. 
This value was supported by randomised clinical trials 
which showed that systolic blood pressure falls 
continuously as sodium is lowered to concentrations as 
low as 1 g per day.47 The 2013 Institute of Medicine report, 
Sodium Intake in Populations: Assessment of Evidence, 
argued that the evidence of the beneﬁ t of lowering 
sodium below 2·3 g per day was unclear.48 The PURE 
cohort study found a J-shaped association between 
urinary sodium excretion, mortality, and major 
cardiovascular events, with minimum risk of death and 
major cardiovascular events observed between 3 g and 
6 g of sodium excretion per day.49 Taking into account the 
potential overestimation of the Kawasaki formula used to 
estimate sodium excretion in PURE, the upper bound of 
minimum risk seems closer to 5 g per day. To account for 
the uncertainty surrounding the concentration of sodium 
that most minimises risk, we sampled a uniform 
distribution ranging from 1 g to 5 g per day to generate 
the TMREL. This choice, however, was controversial 
across the GBD investigators, with several diet 
collaborators proposing an uncertainty interval of 1–3 g 
per day. Following the GBD Study Protocol, the GBD 
Scientiﬁ c Council made the ﬁ nal decision to use an 
uncertainty interval of 1–5 g per day.
For bone mineral density, we used the 99th percentile of 
age–sex subgroups of NHANES III studies between 2005 
and 2010 data instead of 90th percentiles from NHANES III 
(used in GBD 2010). Use of the 99th percentile enables us 
to consider the bone density decrease by age, while 
capturing the excess risk of fracture caused by lower bone 
mineral density observed in elderly populations.
Attributable burden estimated using other approaches
For unsafe sex and occupational injuries for all outcomes, 
we did not use the relative risk and exposure method to 
estimate attributable burden. Because of absence of 
reliable relative risk estimates associating diﬀ erent 
occupations with injury outcomes, we used data for rates 
of fatal injuries reported by industry as related to 
occupation to calculate the PAF. This implicitly assumes 
that the TMREL would be zero for occupation-related 
fatal injuries. In view of the diﬃ  culty of ﬁ tting unsafe sex 
in the exposure–risk framework, we took a direct 
attribution approach and modelled the PAFs directly in 
DisMod-MR 2.0 for HIV. Direct attribution was also used 
for intimate partner violence and homicide, as well as 
drug use and hepatitis B and C.
Burden attributable to clusters of risk factors
There is interest in what fraction of the burden of disease 
is attributable to various combinations of risk factors or 
to all risk factors combined.50,51 To compute the joint risk 
factor burden for metabolic risks and combinations of 
metabolic risk factors with other behavioural or 
environmental risk factors requires assumptions about 
how one risk factor is mediated through other risk 
factors—for example, what fraction of the hazard 
associated with obesity is mediated through blood 
pressure or cholesterol? Recent studies have examined 
the fraction of high BMI mediated through elevated 
cholesterol and systolic blood pressure.52 Consistent with 
this approach for every two risk factors for an outcome, 
we estimated the fraction of risk that is mediated through 
the other risk based on published studies 
(appendix pp 710–11). Using this matrix of parameters 
carrying every two by two combination of the risk factors, 
we have computed the aggregated burden of disease for 
every level including behavioural, environmental and 
occupational, and metabolic risks, and ﬁ nally for all risk 
factors using the following formula:
Where J is a set of risk factors for aggregation, PAFjoasct is 
the population attributable fraction for risk factor i, MFjio 
is mediation factor for risk factor i mediated through j, 
cause o, age-group a and sex s, country c, and time t.
We estimated the joint burden of childhood wasting, 
stunting, and underweight. Published relative risks for 
wasting, stunting, and underweight, however, do not 
control for each other. We adjusted the published 
confounded relative risks for each indicator for the eﬀ ect 
of the other two anthropometric indicators.29 Using the 
adjusted relative risks for all three anthropometric 
indicators, we have calculated the joint PAF for all three 
indicators assuming they were independent.
Role of the funding source
The funder of the study had no role in the study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The authors had access to the data in 
the study and the ﬁ nal responsibility to submit the paper.
Results
The risk factors included in this analysis are estimated to 
account for a widely varying proportion of deaths and 
DALYs across causes at the global level. Figure 2 uses tree 
J
j = 1
J
i = 1
PAFjoasct = 1 – ∏ 1 – PAFjoasct ∏ (1 – MFjio)
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maps to represent the PAFs for all risks combined for 
each disease and injury for level 2 causes in the GBD 
hierarchical cause list for deaths and DALYs. Across the 
level 2 causes, the attributable fractions for deaths range 
from 0% for neonatal disorders to 88·7% 
(95% UI 86·6–90·6) for cardiovascular and circulatory 
diseases. The next highest attributable fractions are 
76·4% (95% UI 70·1–80·1) for diabetes, urogenital, 
blood, and endocrine disorders and 63·6% (61·2–66·1) 
for diarrhoea, lower respiratory infections, and other 
common infectious diseases. Table 2 shows that the 
attributable fraction for deaths due to all causes combined 
for all risk factors is 57·2% (95% UI 55·8–58·5) and the 
fraction for DALYs is 41·6% (40·1–43·0). The attributable 
fraction for YLDs due to non-communicable diseases for 
all risk factors combined (25·8% [24·0–27·6]) is much 
lower than for deaths or YLLs because some of the 
leading causes of YLDs such as mental and substance 
abuse disorders, musculoskeletal disorders, and other 
non-communicable diseases have low attributable 
fractions for the set of risks included in this study. For 
DALYs, in 2013 all risks explained a variable fraction 
ranging from 25·8% (95% UI 24·0–27·6) for injuries, to 
43·8% (41·1–46·3) for non-communicable diseases, and 
42·3% (40·6–44·1) for communicable, maternal, 
neonatal, and nutritional diseases. Within each broad 
disease and injury group, there is also substantial 
variation. Risks account for only 5·8% (95% UI 2·6–8·6) 
for maternal disorders and 0% for neonatal disorders, 
but 87·0 (84·6–89·3) for nutritional deﬁ ciencies. Within 
non-communicable diseases, all risks account for less 
than 6% of DALYs for digestive diseases, neurological 
disorders, and other non-communicable diseases.
To help quantify how each large group of risk factors 
interacts, ﬁ gure 3 shows the fraction of burden for 
diﬀ erent outcomes that is explained by eight exclusive 
groupings: not explained by risks included in this study; 
behavioural risks alone; behavioural risks and 
environmental and occupational risks; behavioural risks 
and metabolic risks; environmental and occupational 
risks alone; environmental and occupational and 
metabolic risks; metabolic risks alone; and the 
intersection of all three groups of risks (ie, behavioural, 
environmental and occupational, and metabolic). For all 
Deaths 2013 YLLs 2013 YLDs 2013 DALYs 2013
All causes 57·2% (55·8−58·5) 47·9% (46·6−49·0) 27·6% (26·6−28·5) 41·6% (40·1−43·0)
Communicable, maternal, neonatal, and nutritional 
diseases
44·1% (42·4−46·0) 40·8% (39·0−42·7) 51·8% (49·0−54·1) 42·3% (40·6−44·1)
HIV/AIDS and tuberculosis 59·8% (55·7−63·9) 58·5% (55·3−62·0) 62·5% (58·8−66·0) 58·7% (55·5−62·2)
Diarrhoea, lower respiratory, and other common 
infectious diseases
62·4% (60·0−64·8) 70·4% (67·6−73·0) 50·1% (41·3−57·6) 69·3% (66·5−71·9)
Neglected tropical diseases and malaria 0 0 0 0
Maternal disorders 6·1% (2·7−9·1) 6·1% (2·8−9·1) 1·4% (0·5−2·5) 5·8% (2·6−8·6)
Neonatal disorders 0 0 0 0
Nutritional deﬁ ciencies 56·8% (50·2−65·2) 78·2% (73·7−82·7) 94·2% (93·2−95·0) 87·0% (84·6−89·3)
Other communicable, maternal, neonatal, and 
nutritional diseases
33·0% (23·5−43·3) 47·6% (35·1−59·6) 38·0% (32·8−46·1) 46·5% (35·3−57·6)
Non-communicable diseases 64·0% (62·3−65·7) 58·9% (56·8−60·7) 23·1% (21·8−24·3) 43·8% (41·1−46·3)
Neoplasms 45·0% (42·1−47·7) 42·5% (39·8−45·1) 32·0% (29·9−34·0) 42·1% (39·4−44·7)
Cardiovascular diseases 88·5% (86·3−90·5) 88·7% (87·4−90·0) 76·5% (73·5−79·5) 87·9% (86·5−89·3)
Chronic respiratory diseases 49·3% (43·2−54·7) 45·3% (39·6−50·3) 44·1% (39·3−49·2) 44·9% (40·2−49·2)
Cirrhosis 57·3% (50·2−62·1) 56·8% (49·1−61·5) 44·3% (40·7−47·3) 56·6% (49·0−61·3)
Digestive diseases 2·0% (1·0−2·8) 2·7% (1·4−3·8) 1·3% (0·7−1·8) 2·4% (1·3−3·3)
Neurological disorders 0·6% (0·4−0·7) 1·9% (1·2−2·5) 1·3% (0·8−1·7) 1·5% (1·0−1·9)
Mental and substance use disorders 93·7% (90·8−94·8) 95·3% (93·1−96·0) 17·6% (16·0−19·4) 22·8% (20·7−25·4)
Diabetes, urogenital, blood, and endocrine diseases 77·6% (73·0−80·9) 64·5% (53·1−72·7) 64·8% (60·0−68·9) 64·5% (57·6−69·6)
Musculoskeletal disorders 0 0 19·9% (17·9−21·9) 19·4% (17·5−21·4)
Other non-communicable diseases 0 0 6·3% (5·4−7·3) 4·4% (3·6−5·2)
Injuries 26·9% (25·4−28·6) 23·3% (21·7−25·1) 38·7% (35·1−41·3) 25·8% (24·0−27·6)
Transport injuries 36·8% (34·3−39·5) 34·0% (31·2−37·0) 44·3% (42·1−46·7) 35·4% (32·7−38·4)
Unintentional injuries 20·0% (17·8−21·9) 12·3% (10·8−14·0) 43·3% (41·5−45·2) 19·1% (16·8−21·4)
Self-harm and interpersonal violence 27·9% (25·2−31·0) 28·2% (25·4−31·4) 26·6% (24·9−28·7) 28·1% (25·4−31·3)
Forces of nature, war, and legal intervention 0·3% (0·2−0·3) 0·1% (0·1−0·2) 1·5% (0·9−2·4) 1·0% (0·6−1·5)
Data are % (95% UI). YLLs=years of life lost. YLDs=years lived with disability. DALYs=disability-adjusted life-years. PAF=population attributable fraction.
 Table 2: The age-standardised PAF attributable to the joint distribution of all risk factors for all ages, both sexes combined for each GBD level 1 and level 2 
cause and all causes for 2013
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causes, all three primary clusters of risks have substantial 
overlap with the smallest proportional overlap being for 
environmental and occupational and metabolic risks. By 
contrast, cardiovascular diseases are dominated by 
metabolic risks and their considerable overlap with 
behavioural risks and environmental and occupational 
risks plays a much smaller role. Behavioural risks with a 
substantial overlap with environmental risks are the key 
Figure 3: Proportion of all-cause DALYs attributable to behavioural, environmental and occupational, and metabolic risk factors and their overlaps for all ages in 2013
DALYs=disability-adjusted life-years. ∩=interaction.
Environmental
% attributed burden: 12·73% (311 956 253 DALYs)
% of total burden: 5·18% (126 900 157 DALYs)
Behavioural ∩ Environmental
% attributed burden: 9·54% (233 666 074 DALYs)
% of total burden: 3·88% (95052627 DALYs)
Behavioural ∩ Environmental ∩ Metabolic
% attributed burden: 5·54% (135 743 126 DALYs)
% of total burden: 2·25% (55 218 717) DALYs)
Behavioural ∩ Metabolic
% attributed burden:
16·74% (410 059 870 DALYs)
% of total burden:
6·81% (166 807 561 DALYs)
Unattributed burden
59·32% (1 453 255 919 DALYs)
Attributed burden
40·68% (99 554 059 DALYs)
Behavioural
% attributed burden: 40·25% (985 974 474 DALYs)
% of total burden: 16·37% (401 082 890 DALYs)
Metabolic
% attributed burden: 13·99% (342 850 762 DALYs)
% of total burden: 5·69% (139 467 682 DALYs)
Environmental ∩ Metabolic
% attributed burden: 1·26% (30 894 509 DALYs)
% of total burden: 0·51% (12 567 525 DALYs)
 
  
Figure 4: Proportion of global all-cause DALYs attributable to behavioural, environmental and occupational, and metabolic risk factors and their overlaps, by 
age for both sexes combined in 2013
DALYs=disability-adjusted life-years. ∩=interaction.
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explanations for neoplasms. For the category of diarrhoea, 
lower respiratory infections, and other common 
infections, there is no contribution from the metabolic 
risks included in this study but environmental and 
occupational and behavioural risks are nearly equal with 
substantial overlap. Figure 4 shows the same breakdown 
of the overlap of the three clusters of risk factors by age. 
Because we have included no risk factors for major 
neonatal causes in this analysis, the fraction explained by 
the three clusters rises rapidly with age in children. The 
fraction explained declines again to a low at 10–14 years. 
In young adults, behavioural risks are the dominant risks 
with an increasing component related to metabolic risks 
at older ages. Environmental risks explain a relatively 
constant share of burden in all age groups.
The leading risk factors globally have changed 
substantially from 2000 to 2013 (ﬁ gure 5; see 
appendix pp 712–20 for 1990 and for results for males and 
females separately). In 2000, the leading cause of 
attributable DALYs (level 2 in the risk hierarchy) was child 
and maternal malnutrition for both males and females, 
accounting for more than one in ten DALYs. Other risks 
Figure 5: Global DALYs attributed to level 2 risk factors in 2000 for both sexes combined (A) and global DALYs attributed to level 2 risk factors in 2013 for 
both sexes combined (B)
DALYs=disability-adjusted life-years.
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Low bone mineral density
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Low bone mineral density
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B
HIV/AIDS and tuberculosis
Diarrhoea, lower respiratory, and other common infectious diseases
Maternal disorders
Nutritional deﬁciencies
Other communicable, maternal, neonatal, and nutritional diseases
Neoplasms
Diabetes, urogenital, blood, and endocrine diseases
Musculoskeletal disorders
Other non-communicable diseases
Transport injuries
Unintentional injuries
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Cardiovascular diseases
Chronic respiratory diseases
Cirrhosis
Digestive diseases
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that are characteristic of poor communities including 
unsafe water, unsafe sanitation and handwashing, and air 
pollution caused nearly 5% each of DALYs for males and 
females. By 2013, child and maternal malnutrition had 
dropped from 10·4% in males and 12·5% in females in 
2000 to 6·55% and 8·02%, respectively. Risks for males at 
the global level in 2013 accounting for more than 5% of 
DALYs were the aggregation of dietary risks, high systolic 
blood pressure, tobacco smoke, alcohol and drug use, 
child and maternal malnutrition, air pollution, high 
fasting plasma glucose, and high BMI. In females, the 
risks in 2013 accounting for more than 5% of DALYs were 
dietary risks, child and maternal malnutrition, high 
systolic blood pressure, high BMI, and air pollution. Other 
risks that account for more than 2% of global DALYs in 
men and women include high fasting plasma glucose, 
unsafe water, unsafe sanitation, lack of handwashing, 
unsafe sex, and high cholesterol. The most notable 
diﬀ erences in the magnitude of risk factors between 
males and females are the more prominent role for 
females of child and maternal malnutrition, high BMI, 
and sexual abuse and violence; whereas in males, tobacco, 
alcohol, and drug use are much more prominent than in 
females.
The global pattern masks tremendous regional variation 
in the proﬁ le of risks, particularly in sub-Saharan Africa 
compared with the rest of the developing and developed 
world. Figure 6 shows the leading risk factors in terms of 
attributable DALYs for sub-Saharan Africa in 2013 for 
both sexes combined: child and maternal malnutrition, 
unsafe sex, and unsafe water, sanitation, and handwashing 
practices. In females, the next most important is air 
pollution (in this case mostly household air pollution) 
and high systolic blood pressure. In males, alcohol and 
drug use is also an important risk factor.
The period 2000–13 was characterised by a major shift in 
the size and relative magnitude of many risk factors 
(ﬁ gure 7). Childhood undernutrition went from the 
number one global risk factor in terms of attributable 
DALYS to the fourth in 2013, a drop of 45% (39–51) in the 
number of DALYs. Unsafe water declined 37% (30–44) 
dropping from fourth to eighth; likewise unsafe sanitation 
dropped from ninth to 16th. Suboptimal breastfeeding 
declined 40% (32–47) from rank 11 to rank 19. Unsafe sex 
went from 10th to 9th from 2000 to 2013; it should be noted 
that the peak attributable burden associated with unsafe 
sex was in 2005. Several risks related to non-communicable 
diseases have risen in prominence. High systolic blood 
pressure increased from second to ﬁ rst. Smoking 
increased from third to second. High BMI increased from 
ﬁ fth to third and high fasting plasma glucose also increased 
from eighth to ﬁ fth. Ambient particulate matter pollution 
increased 6% (1–12) leading to a rank increase from 13th to 
12th. Several diet components—most notably low fruit, 
high sodium, and low whole grains—increased in rank 
and absolute attributable burden over the period. We can 
isolate the impact of changes in population size and age 
composition by examining the change in the number of 
attributable DALYs compared with the change in the age-
standardised rate of attributable DALYs. In fact, only ﬁ ve 
risk factors had increases in the age-standardised 
attributable DALY rate: unsafe sex, diet high in red meat, 
Figure 6: Global DALYs attributed to level 2 risk factors in 2013 for sub-Saharan Africa for both sexes combined
DALYs=disability-adjusted life-years.
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diet high in sugar-sweetened beverages, occupational 
carcinogens, and drug use. In terms of the number of 
attributable DALYs, seven risks declined: vitamin A 
deﬁ ciency, childhood undernutrition, unsafe sanitation, 
secondhand smoke, no handwashing with soap, unsafe 
water, and suboptimal breastfeeding. Among the 
components of unsafe water, sanitation, and 
handwashing, the most important is unsafe water 
followed by unsafe sanitation and then no handwashing 
with soap. 
Deaths and DALYs for all ages and both sexes combined 
for the full risk factor hierarchy are provided in table 3. 
Appendix pp 52–87 provides a further breakdown for 
each risk–outcome pair. All risk factors combined 
accounted for 25·1 million deaths in 1990, increasing by 
more than one-ﬁ fth to 30·8 million deaths in 2013. 
Although the number of deaths attributed to all risks 
increased substantially, the global all-risk all-cause PAF 
increased only 3·4 percentage points from 52·8% to 
56·2%. The trends in DALYs attributed to all risk factors 
are quite diﬀ erent than those for deaths: total DALYs did 
not change from 1990 to 2013 and the PAF decreased by 
0·05 of a percentage point. For most risks that aﬀ ect 
non-communicable diseases, the number of deaths or 
DALYs that are attributable to those risks increased; 
however, the age-standardised PAF increased by more 
than 10% for a subset of risks, including most 
occupational carcinogens, occupational noise, 
occupational ergonomic factors, alcohol use, drug use, 
diet low in whole grains, diet low in milk, diet high in red 
meat, diet high in processed meat, diet high in sugar-
sweetened beverages, diet with suboptimal calcium, 
intimate partner violence, unsafe sex, low physical 
activity, high fasting plasma glucose, high systolic blood 
pressure, high BMI, and low glomerular ﬁ ltration rate.
In most cases, the trend in the number of deaths 
attributed to a risk factor is similar to the trend in the 
number of DALYs attributable to the same risk from 1990 
to 2013. Diﬀ erences in the rates reﬂ ect the age pattern of 
the attributable events for a risk. An unusual case is air 
pollution, for which the number of attributable deaths 
increased but attributable DALYs declined. This ﬁ nding 
is due to the trends for ambient particulate matter 
pollution, for which deaths increased from 2·2 million to 
2·9 million deaths, and household air pollution from 
solid fuels for which deaths remained constant at 
2·9 million. Because deaths due to household air 
pollution on average occur at much younger ages, the 
trend in this risk drives the overall trend in the joint risk 
of air pollution.
The combined eﬀ ect of air pollution was 5·5 million 
deaths in 2013 and 141·5 million DALYs. There were 
roughly equal contributions from household air pollution 
(2·9 million deaths and 81·1 million DALYs in 2013) and 
ambient particulate matter pollution (2·9 million deaths 
and 69·7 million DALYs in 2013). Lead exposure accounted 
Figure 7: The 25 leading level 3 global risk factors for DALYs in both sexes combined in 2000 and 2013
2000 leading risks
Mean rank
(95% UI)
Mean rank
(95% UI)2013 leading risks
All age
median % change
Age-standardised
median % change
 1·0 (1–1) 1 Childhood undernutrition
 2·0 (2–2) 2 High blood pressure
 3·3 (3–4) 3 Smoking
 4·0 (3–6) 4 Unsafe water
 5·2 (4–8) 5 High body–mass index
 6·9 (5–11) 6 Alcohol use
 7·6 (5–11) 7 Household air pollution
 7·9 (5–11) 8 High fasting plasma glucose
 9·2 (6–12) 9 Unsafe sanitation
 11·5 (8–14) 10 Unsafe sex
 12·0 (6–17) 11 Suboptimal breastfeeding
 12·6 (7–18) 12 Low fruit
 13·8 (12–15) 13 Ambient particulate matter
 13·9 (6–22) 14 High sodium
 15·9 (13–19) 15 High total cholesterol
 17·3 (14–21) 16 Iron deﬁciency
 17·3 (15–21) 17 Handwashing
 18·8 (16–21) 18 Low whole grains
 19·6 (18–22) 19 Low glomerular ﬁltration
 21·0 (19–22) 20 Low vegetables
 21·1 (19–22) 21 Low physical activity
 23·9 (23–27) 22 Low nuts and seeds
 25·0 (23–30) 23 Vitamin A deﬁciency
 25·3 (23–28) 24 Drug use
 27·2 (24–32) 25 Low omega-3
  26 Low ﬁbre
1 High blood pressure 1·0 (1–1) 20% (15 to 26) –13% (–16 to –9)
2 Smoking 2·6 (2–4) 5% (–1 to 11) –23% (–28 to –19)
3 High body–mass index 2·8 (2–5) 26% (22 to 31) –7% (–11 to –5)
4 Childhood undernutrition 4·2 (3–6) –45% (–51 to –39) –50% (–55 to –44)
5 High fasting plasma glucose 4·6 (3–6) 31% (25 to 36) –4% (–8 to 0)
6 Alcohol use 6·9 (5–9) 6% (2 to 11) –17% (–20 to –13)
7 Household air pollution 9·1 (8–12) –10% (–21 to 2) –28% (–38 to –18)
8 Unsafe water 10·4 (8–14) –37% (–44 to –30) –43% (–49 to –37)
9 Unsafe sex 10·8 (8–13) –3% (–11 to 7) –20% (–26 to –11)
10 Low fruit 10·8 (7–16) 7% (1 to 14) –22% (–26 to –16)
11 High sodium 11·4 (5–20) 15% (7 to 24) –16% (–22 to –10)
12 Ambient particulate matter 11·9 (10–14) 6% (1 to 12) –17% (–21 to –13)
13 High total cholesterol 13·4 (9–17) 13% (6 to 22) –18% (–23 to –12)
14 Low glomerular ﬁltration 15·8 (14–18) 24% (19 to 30) –7% (–11 to –3)
15 Low whole grains 16·3 (13–20) 17% (12 to 23) –14% (–18 to –10)
16 Unsafe sanitation 17·0 (14–20) –42% (–48 to –36) –47% (–53 to –42)
17 Low physical activity 18·5 (16–21) 20% (15 to 27) –13% (–17 to –9)
18 Iron deﬁciency 18·6 (14–22) –10% (–14 to –7) –19% (–22 to –16)
19 Suboptimal breastfeeding 18·6 (14–23) –40% (–47 to –32) –44% (–51 to –37)
20 Low vegetables 20·2 (18–22) 4% (–2 to 10) –24% (–28 to –20)
21 Handwashing 22·5 (21–25) –37% (–44 to –31) –43% (–49 to –37)
22 Drug use 23·1 (22–25) 33% (27 to 40) 10% (5 to 15)
23 Low nuts and seeds 24·0 (21–28) 2% (–3 to 8) –25% (–29 to –21)
24 Low omega-3 25·9 (23–29) 16% (7 to 27) –15% (–21 to –7)
25 Low ﬁbre 26·1 (24–28) 15% (3 to 29) –16% (–24 to –5)
36 Vitamin A deﬁciency
Environmental Behavioural Metabolic
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1990 deaths (in 
thousands)
2013 deaths (in 
thousands)
Median percent 
change deaths
Median percent 
change of age-
standardised 
deaths PAF
1990 DALYs (in 
thousands)
2013 DALYs (in 
thousands)
Median percent 
change DALYs
Median percent 
change of age-
standardised 
DALYs PAF
All risk factors 25 085
(24 385 to 25 821)
30 839
( 29 719 to 31 949)
23·0%
(19·0 to 27·3)
0·6%
(−1·0 to 2·0)
1 035 987
(980 813 to 1 092 478)
996 554
(927 157 to 1 072 340)
−3·8%
(−7·7 to −0·1)
−3·8%
(−6·0 to −1·8)
Environmental risks 8492
(8036 to 8953)
8181
(7651 to 8726)
−3·7%
(−9·6 to 2·4)
−15·5%
(−19·8 to 11·1)
400 345
(374 489 to 424 432)
289 517
(265 778 to 312 094)
−27·7%
(−32·1 to −23·2)
−22·6%
(−26·1 to −19·1)
Unsafe water, 
sanitation, and 
handwashing
2727
(2530 to 2952)
1399
(1237 to 1576)
−48·8%
(−53·6 to −43·7)
−44·9%
(−49·6 to −40·0)
190 423
(174 685 to 208 033)
83 867
(72 879 to 95 568)
−56·0%
(−60·6 to −50·9)
−45·6%
(−50·8 to −40·1)
Unsafe water source 2434
(1971 to 2763)
1246
(989 to 1464)
−48·8%
(−53·7 to −43·9)
−45·0%
(−49·7 to −40·1)
170 053
(137 216 to 193 963)
75 125
(59 952 to 89 756)
−55·9%
(−60·4 to −50·8)
−45·5%
(−50·7 to −40·0)
Unsafe sanitation 1785
(1613 to 1959)
816
(707 to 921)
−54·4%
(−58·8 to −49·8)
−51·1%
(−55·5 to −46·9)
124 049
(111 394 to 137 303)
49 039
(41 770 to 56 227)
−60·5%
(−64·8 to −56·0)
−51·3%
(−56·3 to −46·4)
No handwashing 
with soap
1010
(798 to 1204)
517
(408 to 621)
−48·9%
(−53·7 to −43·8)
−45·0%
(−49·8 to −40·2)
70 389
(55 414 to 84 417)
30 721
(24 281 to 37 626)
−56·4%
(−60·9 to −51·6)
−46·1%
(−51·3 to −40·5)
Air pollution 4808
(4459 to 5157)
5527
(5109 to 5944)
14·8%
(5·8 to 25·3)
−8·0%
(−15·0 to −0·2)
157 831
(145 269 to 171 007)
141 456
(130 071 to 153 652)
−10·5%
(−17·4 to −2·8)
−12·7%
(−19·2 to −5·7)
Ambient particulate 
matter pollution
2238
(2154 to 2317)
2926
(2777 to 3066)
30·7%
(25·2 to 36·5)
2·9%
(0·7 to 5·1)
68 120
(64 972 to 71 405)
69 673
(65 585 to 73 552)
2·3%
(−3·4 to 8·2)
−3·0%
(−6·6 to 0·8)
Household air 
pollution from solid 
fuels
2857
(2482 to 3216)
2893
(2463 to 3303)
1·3%
(−13·4 to 18·8)
−17·2%
(−30·0 to −2·8)
101 643
(88 877 to 115 053)
81 087
(70 025 to 92 802)
−20·2%
(−29·5 to −9·4)
−20·4%
(−30·5 to −9·1)
Ambient ozone 
pollution
133
(105 to 162)
217
(161 to 272)
63·8%
(14·5 to 125·1)
19·8%
(−16·3 to 60·6)
3038
(2296 to 3814)
5073
(3576 to 6620)
66·9%
(12·2 to 137·1)
32·5%
(−11·0 to 84·6)
Other environmental 
risks
731
(523 to 965)
945
(663 to 1279)
29·2%
(17·1 to 40·5)
−1·9%
(−9·2 to 4·7)
17 015
(12 567 to 22 173)
18 822
(13 300 to 25 407)
10·5%
(0·4 to 20·1)
−9·4%
(−16·6 to −2·3)
Residential radon 63
(41 to 86)
92
(61 to 128)
46·3%
(13·1 to 87·9)
13·8%
(−11·7 to 44·3)
1503
(984 to 2086)
1979
(1331 to 2768)
31·7%
(2·4 to 67·6)
7·1%
(−17· to − 36·9)
Lead exposure 668
(465 to 899)
853
(572 to 1181)
27·6%
(15·1 to 39·1)
−3·3%
(−10·8 to 3·7)
15 512
(10 967 to 20 727)
16 843
(11 494 to 23 505)
8·5%
(−2·4 to 18·3)
−10·9%
(−18·9 to −3·8)
Occupational risks 562
(509 to 629)
717
(641 to 803)
27·7%
(13·4 to 42·5)
4·0%
(−5·7 to 14·0)
43 879
(35 819 to 52 859)
55 352
(44 589 to 67 890)
26·2%
(16·3 to 36·1)
10·2%
(2·9 to 18·0)
Occupational 
carcinogens
152
(135 to 174)
304
(263 to 341)
100·7%
(78·5 to 116·2)
52·4%
(36·1 to 63·6)
3149
(2789 to 3543)
5803
(5076 to 6526)
84·7%
(66·2 to 101·4)
48·5%
(34·2 to 60·8)
Occupational 
exposure to 
asbestos
94
(76 to 116)
194
(155 to 233)
109·6%
(72·4 to 132·2)
56·2%
(28·9 to 74·2)
1773
(1425 to 2211)
3402
(2725 to 4113)
93·4%
(63·5 to 117·3)
53·4%
(29·9 to 72·4)
Occupational 
exposure to 
polycyclic 
aromatic 
hydrocarbons
3
(2 to 3)
6
(5 to 7)
120·2%
(101·8 to 139·3)
71·4%
(58·4 to 85·1)
60
(51 to 71)
125
(102 to 146)
105·9%
(88·3 to 126·2)
67·4%
(52·8 to 82·7)
Occupational 
exposure to silica
11
(10 to 12)
21
(19 to 24)
95·8%
(78·9 to 112·6)
52·8%
(41·3 to 64·1)
248
(223 to 274)
454
(404 to 509)
83·0%
(67·3 to 100·1)
49·0%
(35·8 to 61·9)
Occupational 
exposure to 
sulphuric acid
3
(2 to 4)
4
(3 to 5)
29·6%
(16·8 to 48·3)
0·8%
(−8·8 to 13·1)
68
(49 to 91)
83
(60 to 113)
21·3%
(9·6 to 40·5)
−1·5%
(−11·6 to 12·1%)
Occupational 
exposure to 
trichloroethylene
0
(0 to 0)
0
(0 to 0)
100·2%
(88·5 to 112·2)
54·3%
(46·1 to 62·7)
1
(0 to 2)
2
(0 to 3)
88·5%
(77·3 to 100·2)
51·7%
(42·9 to 61·1)
Occupational 
exposure to 
arsenic
2
(2 to 3)
4
(3 to 4)
72·7%
(56·4 to 90·8)
34·7%
(23·4 to 46·8)
47
(38 to 58)
76
(60 to 94)
61·3%
(46·0 to 79·3)
31·3%
(18·6 to 44·9)
Occupational 
exposure to 
benzene
2
(1 to 2)
3
(2 to 3)
66·2%
(57·2 to 75·5)
32·3%
(25·8 to 37·8)
59
(51 to 68)
95
(81 to 108)
59·4%
(50·3 to 69·1)
36·8%
(29·1 to 44·4)
Occupational 
exposure to 
beryllium
0
(0 to 0)
0
(0 to 0)
44·3%
(30·6 to 62·7)
12·6%
(3·0 to 25·3)
2
(2 to 3)
3
(3 to 4)
34·7%
(21·6 to 53·2)
9·1%
(−2·0 to 22·3%)
(Table 3 continues on next page)
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1990 deaths (in 
thousands)
2013 deaths (in 
thousands)
Median percent 
change deaths
Median percent 
change of age-
standardised 
deaths PAF
1990 DALYs (in 
thousands)
2013 DALYs (in 
thousands)
Median percent 
change DALYs
Median percent 
change of age-
standardised 
DALYs PAF
(Continued from previous page)
Occupational 
exposure to 
cadmium
0
(0 to 0)
1
(1 to 1)
116·6%
(97·0 to 137·4%)
68·6%
(54·9 to 82·2)
8
(7 to 9)
16
(13 to 19)
102·8%
(84·4 to 123·2)
64·9%
(49·7 to 80·1)
Occupational 
exposure to 
chromium
1
(1 to 1)
3
(2 to 3)
116·2%
(96·7 to 136·7)
68·3%
(54·8 to 81·4)
28
(25 to 32)
57
(50 to 65)
102·3%
(83·8 to 123·6)
64·6%
(48·9 to 80·4)
Occupational 
exposure to diesel 
engine exhaust
17
(15 to 20)
37
(32 to 43)
116·6%
(99·4 to 134·9)
69·1%
(57·2 to 81·3)
394
(343 to 449)
797
(690 to 913)
102·0%
(84·6 to 120·8)
64·4%
(50·5 to 78·5)
Occupational 
exposure to 
second-hand 
smoke
19
(17 to 20)
34
(31 to 37)
80·5%
(66·8 to 94·8)
40·6%
(31·5 to 50·0)
431
(393 to 465)
725
(660 to 794)
68·1%
(54·7 to 83·8)
36·7%
(26·0 to 48·3)
Occupational 
exposure to 
formaldehyde
1
(0 to 1)
1
(1 to 1)
51·1%
(34·2 to 67·8)
20·9%
(9·3 to 32·2)
20
(16 to 25)
29
(23 to 35)
43·3%
(26·9 to 59·7)
21·3%
(8·6 to 34·3)
Occupational 
exposure to 
nickel
6
(4 to 8)
12
(9 to 16)
103·0%
(82·2 to 123·6)
58·0%
(42·7 to 73·1)
135
(103 to 173)
257
(193 to 326)
90·5%
(70·8 to 110·7)
54·6%
(38·4 to 71·0)
Occupational 
asthmagens
63
(48 to 93)
52
(42 to 70)
−18·4%
(−32·9 to 5·2)
−34·2%
(−46·8 to −17·1)
2903
(2310 to 3909)
2771
(2227 to 3521)
−4·7%
(−18·1 to 12·0)
−18·1%
(−30·5 to −4·4)
Occupational 
particulate matter, 
gases, and fumes
197
(161 to 236)
205
(164 to 251)
3·7%
(−7·6 to 17·6)
−18·8%
(−26·7 to −9·9)
7212
(5877 to 8545)
8802
(7012 to 10 740)
22·0%
(10·9 to 34·0)
−0·6%
(−8·4 to 8·0)
Occupational noise .. .. .. .. 5039
(3268 to 7193)
7119
(4549 to 10 329)
41·4%
(33·9 to 48·0)
21·4%
(15·1 to 27·8)
Occupational 
injuries
151
(122 to 197)
159
(127 to 206)
4·4%
(−24·6 to 49·2)
−4·7%
(−32·6 to 34·2)
9776
(7809 to 12 884)
9947
(7886 to 12 927)
1·3%
(−26·0 to 42·5)
−2·9%
(−29·9 to 34·2)
Occupational 
ergonomic factors
.. .. .. .. 15 944
(10 747 to 22 276)
21 109
(14 206 to 29 304)
32·2%
(28·0 to 37·7)
16·2%
(11·2 to 21·8)
Behavioural risks 18 453
(17 419 to 19 480)
21 909
(20 446 to 23 383)
18·7%
(14·5 to 23·1)
−0·7%
(−2·4 to 1·0)
799 073
(753 589 to 844 178)
717 608
(667 831 to 771 924)
−10·2%
(−14·1 to −6·1)
−7·4%
(−9·8 to −5·1)
Child and maternal 
malnutrition
4254
(3937 to 4555)
1665
(1487 to 1840)
−60·8%
(−65·0 to −57·1)
−50·5%
(−55·9 to −45·5)
403 951
(371 608 to 432 910)
176 859
(156 431 to 199 831)
−56·1%
(−60·6 to −52·2)
−43·2%
(−47·9 to 
−38·9)
Childhood 
undernutrition
3635
(3341 to 3888)
1327
(1169 to 1481)
−63·4%
(−67·6 to −59·6)
−53·2%
(−58·6 to −48·1)
317 851
(292 419 to 339 549)
119 802
(106 565 to 133 359)
−62·2%
(−66·3 to −58·5)
−49·9%
(−55·1 to −45·0)
Childhood 
underweight
1080
(886 to 1288)
386
(309 to 463)
−64·2%
(−70·5 to −57·9)
−54·0%
(−62·1 to −45·8)
95 709
 (79 446 to 113 315)
35 806
(29 108 to 42 575)
−62·5%
(−68·9 to −56·3)
−50·2%
(−58·3 to −42·4)
Childhood 
wasting
3295
(2802 to 3696)
1247
(1034 to 1413)
−62·0%
(−66·5 to −57·4)
−51·4%
(−57·1 to −45·2)
288 145
(246 038 to 322 526)
112 350
(94 437 to 127 169)
−60·9%
(−65·4 to −56·3)
−48·2%
(−53·8 to −42·2)
Childhood 
stunting
848
(474 to 1339)
218
(107 to 389)
−74·6%
(−79·5 to −68·9)
−67·3%
(−73·9 to −60·0)
73 355
(40 848 to 115 668)
19 291
(9581 to 34 208)
−73·9%
(−79·0 to −68·6)
−65·4%
(−72·2 to −58·1)
Suboptimal 
breastfeeding
1344
(904 to 1834)
501
(318 to 697)
−62·8%
(−67·5 to −58·0)
−52·1%
(−58·3 to −45·5)
116 801
(78 740 to 158 958)
44 203
(28 205 to 61 650)
−62·3%
(−66·8 to −57·6)
−49·6%
(−55·7 to −43·4)
Non-exclusive 
breastfeeding
1155
(743 to 1606)
442
(264 to 641)
−61·9%
(−66·8 to −56·9)
−50·7%
(−57·3 to −43·9)
99 927
(64 457 to 138 645)
38 502
(23 037 to 55 565)
−61·7%
(−66·5 to −56·7)
−48·7%
(−55·1 to −42·1)
Discontinued 
breastfeeding
191
(65 to 349)
59
(20 to 110)
−69·3%
(−74·6 to −63·0)
−60·5%
(−67·3 to −52·5)
17 046
(5804 to 31 059)
5722
(1898 to 10 599)
−66·6%
(−71·7 to −60·5)
−55·4%
(−62·1 to −47·6)
Iron deﬁ ciency 241
(169 to 344)
199
(137 to 275)
−17·1%
(−33·7 to −0·5)
−21·8%
(−35·6 to −7·7)
53 019
(38 674 to 71 446)
44 651
(31 844 to 62 304)
−15·6%
(−21·5 to −11·5)
−6·5%
(−11·3 to −2·0)
Vitamin A 
deﬁ ciency
377
(247 to 522)
85
(51 to 125)
−77·4%
(−82·9 to −71·5)
−71·0%
(−78·2 to −63·7)
32 920
(21 694 to 45 629)
7875
(4758 to 11 541)
−76·1%
(−81·6 to −70·3)
−68·3%
(−75·6 to −60·9)
Zinc deﬁ ciency 221
(15 to 491)
66
(4 to 153)
−70·1%
(−76·3 to −62·7)
−61·2%
(−69·8 to −52·4)
19 188
(1816 to 41 961)
5996
(745 to 13 267)
−68·4%
(−74·4 to −56·7)
−57·3%
(−66·1 to −42·6)
(Table 3 continues on next page)
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1990 deaths (in 
thousands)
2013 deaths (in 
thousands)
Median percent 
change deaths
Median percent 
change of age-
standardised 
deaths PAF
1990 DALYs (in 
thousands)
2013 DALYs (in 
thousands)
Median percent 
change DALYs
Median percent 
change of age-
standardised 
DALYs PAF
(Continued from previous page)
Tobacco smoke 5229
(4816 to 5681)
6149
(5587 to 6762)
17·8%
(10·9 to 23·9)
−9·6%
(−13·2 to −6·3)
142 341
(131 399 to 153 920)
143 512
(129 979 to 159 147)
0·7%
(−5·5 to 7·5)
−14·5%
(−18·9 to −10·2)
Smoking 4634
(4222 to 5079)
5818
(5258 to 6435)
25·7%
(17·9 to 32·6)
−5·1%
(−9·3 to −1·3)
115 910
(105 383 to 127 110)
134 196
(120 872 to 149 759)
15·8%
(8·6 to 23·6)
−7·4%
(−12·4 to −2·2)
Second hand smoke 595
(540 to 654)
331
(308 to 355)
−44·4%
(−48·2 to −40·0)
−50·9%
(−53·6 to −48·2)
26 431
(22 494 to 30 676)
9316
(8417 to 10,277)
−64·7%
(−68·3 to −60·8)
−60·2%
(−63·3 to −56·9)
Alcohol and drug use 2092
(1671 to 2438)
3163
(2537 to 3656)
51·3%
(44·3 to 58·4)
19·4%
(15·3 to 23·7)
89 844
(76 788 to 101 767)
126 053
(107 154 to 142 356)
40·2%
(34·8 to 46·3)
23·5%
(18·9 to 28·3)
Alcohol use 1977
(1555 to 2329)
2786
(2146 to 3287)
40·9%
(33·2 to 47·9)
11·1%
(6·9 to 14·8)
76 029
(63 443 to 87 186)
99 278
(81 295 to 113 616)
30·5%
(23·9 to 37·0)
13·6%
(8·6 to 18·1)
Drug use 132
(109 to 155)
429
(381 to 480)
224·8%
(188·0 to 273·4)
179·5%
(147·0 to 222·3)
14 481
(11 607 to 17 286)
28 578
(24 505 to 33 104)
97·4%
(83·2 to 114·8)
89·3%
(74·3 to 107·1)
Dietary risks 8068
(6991 to 9159)
11 274
(9656 to 12 957)
39·6%
(34·1 to 46·2)
2·9%
(0·3 to 5·8)
177 408
(154 661 to 200 097)
241 351
(209 634 to 273 339)
35·9%
(29·8 to 43·0)
7·7%
(4·1 to 12·0)
Diet low in fruits 2540
(1686 to 3367)
3413
(2207 to 4546)
33·9%
(25·6 to 43·3)
0·1%
(−5·2 to 5·9)
58 710
(39 575 to 76 928)
74 797
(49 434 to 98 791)
27·0%
(19·0 to 36·0)
1·7%
(−3·8 to 7·9)
Diet low in 
vegetables
1381
(1094 to 1684)
1782
(1405 to 2173)
28·9%
(22·3 to 36·6)
−4·8%
(−9·4 to −0·1)
31 283
(24 692 to 38 039)
39 176
(31 050 to 47 658)
25·2%
(17·9 to 33·2)
−0·4%
(−5·4 to 5·1)
Diet low in whole 
grains
1396
(1066 to 1728)
2049
(1575 to 2525)
46·8%
(40·8 to 54·2)
9·2%
(5·9 to 13·1)
34 807
(26 736 to 43 078)
51 411
(39 500 to 63 286)
47·6%
(40·9 to 56·0)
18·0%
(13·9 to 22·9)
Diet low in nuts and 
seeds
1012
(725 to 1304)
1195
(816 to 1578)
17·7%
(10·5 to 25·0)
−13·3%
(−18·7 to −8·5)
23 434
(16 643 to 30 134)
27 109
(18 408 to 36 030)
15·3%
(8·0 to 22·8)
−8·5%
(−13·7 to −3·3)
Diet low in milk 66
(19 to 111)
105
(30 to 177)
58·1%
(51·9 to 63·8)
18·4%
(14·6 to 22·2)
1515
(434 to 2538)
2218
(633 to 3713)
46·3%
(39·8 to 52·5)
17·2%
(12·6 to 21·6)
Diet high in red 
meat
62
(55 to 70)
102
(89 to 116)
64·1%
(52·8 to 75·8)
23·0%
(14·4 to 32·0)
2201
(1854 to 2585)
4147
(3349 to 5026)
88·2%
(75·9 to 101·6)
50·7%
(41·9 to 60·4)
Diet high in 
processed meat
457
(332 to 622)
644
(467 to 881)
41·4%
(24·1 to 57·9)
4·4%
(−8·6 to 17·1)
11 745
(8676 to 15 897)
17 380
(12 677 to 23 925)
47·9%
(30·9 to 64·0)
17·3%
(3·4 to 29·4)
Diet high in 
sugar-sweetened 
beverages
60
(44 to 82)
126
(96 to 166)
110·1%
(88·7 to 141·4)
64·4%
(45·7 to 87·2)
2712
(2006 to 3635)
6190
(4665 to 8142)
128·4%
(105·4 to 159·0)
89·6%
(70·2 to 115·3)
Diet low in ﬁ bre 716
(587 to 853)
1009
(817 to 1207)
40·6%
(25·3 to 60·0)
4·2%
(−7·4 to 18·0)
16 395
(13 496 to 19 433)
22 098
(17 996 to 26 349)
35·0%
(18·6 to 52·4)
7·4%
(−5·1 to 20·6)
Diet suboptimal in 
calcium
85
(74 to 97)
141
(122 to 160)
64·6%
(53·6 to 80·4)
22·9%
(15·2 to 33·1)
1870
(1605 to 2143)
2876
(2507 to 3258)
53·5%
(42·8 to 66·9)
22·9%
(15·5 to 33·0)
Diet low in seafood 
omega-3 fatty acids
712
(530 to 909)
1031
(769 to 1304)
44·6%
(35·3 to 57·3)
7·5%
(1·9 to 14·3)
16 285
(12 321 to 20 657)
22 448
(16 887 to 28 205)
37·6%
(27·7 to 52·7)
10·1%
(2·8 to 19·8)
Diet low in 
polyunsaturated 
fatty acids
447
(404 to 493)
581
(512 to 651)
29·6%
(16·9 to 44·7)
−4·5%
(−13·7 to 5·2)
10 033
(9051 to 11 040)
12 670
(11 103 to 14 342)
25·9%
(13·0 to 41·8)
0·0%
(−9·8 to 11·6)
Diet high in trans 
fatty acids
464
(311 to 650)
405
(218 to 645)
−15·0%
(−34·0 to 3·7)
−38·3%
(−52·2 to −24·5)
10 644
(7 131 to 14 859)
9875
(5503 to 15 228)
−8·5%
(−29·0 to 9·6)
−28·7%
(−43·6 to −14·7)
Diet high in sodium 2562
(1377 to 4041)
3689
(2028 to 5810)
44·1%
(33·8 to 57·1)
7·4%
(1·3 to 15·5)
54 620
(29 271 to 86 008)
74 327
(40 615 to 116 717)
36·2%
(26·5 to 48·7)
8·4%
(1·5 to 17·5)
Sexual abuse and 
violence
163
(141 to 188)
257
(203 to 312)
57·5%
(30·6 to 83·7)
36·7%
(14·9 to 58·9)
15 133
(12 297 to 18 621)
21 290
(16 743 to 26 065)
40·6%
(26·4 to 55·7)
31·8%
(19·1 to 46·0)
Childhood sexual 
abuse
64
(53 to 78)
68
(55 to 82)
5·9%
(−9·3 to 19·9)
−7·4%
(−21·4 to 3·9)
6896
(5364 to 8667)
7682
(5910 to 9736)
11·4%
(4·0 to 18·8)
5·8%
(−1·6 to 12·6)
Intimate partner 
violence
106
(86 to 130)
197
(146 to 251)
85·9%
(49·6 to 124·8)
60·9%
(30·5 to 93·6)
9009
(7076 to 11 440)
14 454
(11 027 to 18 164)
60·6%
(39·6 to 85·1)
48·8%
(29·3 to 71·7)
Unsafe sex 679
(561 to 827)
1481
(1383 to 1621)
118·8%
(86·2 to 158·1)
100·5%
(76·6 to 129·3)
39 761
(30 789 to 52 320)
73 282
(67 015 to 82 478)
86·1%
(51·7 to 127·0)
97·6%
(68·3 to 131·3)
(Table 3 continues on next page)
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for an increased number of deaths in 2013 as compared 
with 1990 (853 000 compared with 668 000). Taken together, 
occupational carcinogens caused 304 000 deaths globally in 
2013 and 5·8 million DALYs; asbestos exposure accounted 
for nearly two-thirds of the burden of all occupational 
carcinogens. In total, occupational risks accounted for 
55·4 million DALYs, of which occupational ergonomic 
factors accounted for 38·1%. As a cluster, childhood 
undernutrition accounted for 1·3 million child deaths in 
2013 and 120 million DALYs. Iron deﬁ ciency, vitamin A 
deﬁ ciency, and zinc deﬁ ciency each accounted for less 
than 200 000 deaths; however, iron deﬁ ciency is a major 
cause of DALYs due to its crucial role as a cause of anaemia.
The number of deaths attributable to tobacco smoking 
continued to increase from 4·6 million in 1990 to 
5·8 million in 2013, and from 115·9 million DALYs to 
134·2 million DALYs over the same period. Secondhand 
smoke accounted for an additional 331 000 deaths and 
9·3 million DALYs. Alcohol use accounted for 2·8 million 
deaths and 99·3 million DALYs in 2013, with both deaths 
and DALYs increasing over time. Among the components 
of diet, the most important in terms of deaths and DALYs 
in 2013 were diets high in sodium and low in fruit, followed 
by low whole grains and low vegetables. Among the 
metabolic risks, high systolic blood pressure is more than 
twice as important as the next most important factor—
high BMI, followed by high fasting plasma glucose.
One simple way to examine the complex results by 
country is to examine the leading risk factor in terms of 
DALYs with risk factors broken down to level 3 in the 
risk factor hierarchy (ﬁ gure 8). For men (ﬁ gure 8A), a 
large set of countries from North Africa and the Middle 
East through to south Asia and east Asia and into Eastern 
Europe have high systolic blood pressure as their leading 
risk. Another broad set of countries in west, east, and 
central sub-Saharan Africa have childhood 
undernutrition as the leading risk. Unsafe sex is the 
leading risk in a set of countries in east and southern 
Africa with large HIV epidemics. Tobacco is the leading 
risk in most high-income countries and alcohol use is 
the leading risk in many countries in Latin America. For 
women (ﬁ gure 8B), the pattern is notably diﬀ erent. High 
BMI is the leading risk for most countries in North and 
South America with only three exceptions (Canada, 
Guatemala, and Uruguay). High BMI is also the leading 
risk in Spain, France, Switzerland, Belgium, most of 
North Africa and the Middle East, Australia, and New 
Zealand. High systolic blood pressure is the leading risk 
in most of Central and Eastern Europe, central Asia, 
south Asia, and east Asia. Cambodia stands out as 
having household air pollution as the top risk factor for 
women. In sub-Saharan Africa, the leading risks are 
undernutrition and unsafe sex for both men and women 
in sub-Saharan Africa.
Figure 9 provides the ten leading risk factors in terms 
of attributable DALYs (level 3 in the risk hierarchy) for 
each country in 2013 for both sexes combined. The top 
15 global risks have been coloured to highlight where 
country and regional patterns diverge from global 
patterns. In high-income regions, most countries had 
high BMI, high systolic blood pressure, and smoking as 
the top three risks. Brunei, Singapore, and Japan had 
high fasting plasma glucose in the top three. Alcohol use 
was the second leading risk in South Korea. Low 
glomerular ﬁ ltration rate was an important risk in 
several countries such as Italy. In Central Europe, 
1990 deaths (in 
thousands)
2013 deaths (in 
thousands)
Median percent 
change deaths
Median percent 
change of age-
standardised 
deaths PAF
1990 DALYs (in 
thousands)
2013 DALYs (in 
thousands)
Median percent 
change DALYs
Median percent 
change of age-
standardised 
DALYs PAF
(Continued from previous page)
Low physical activity 1489
(1257 to 1741)
2182
(1858 to 2555)
46·5%
(40·9 to 52·9)
6·4%
(4·0 to 9·2)
31 247
(26 556 to 36 521)
45 143
(38 328 to 52 671)
44·3%
(37·2 to 52·8)
13·6%
(9·4 to 18·3)
Metabolic risks 10 398
(9811 to 11 003)
15 723
(14 719 to 16 767)
51·2%
(46·2 to 57·0)
10·6%
(8·8 to 12·6)
250 957
(233 711 to 267 582)
373 817
(343 978 to 403 889)
48·9%
(43·1 to 54·9)
18·4%
(15·3 to 21·7)
High fasting plasma 
glucose
2444
(2101 to 2853)
4014
(3499 to 4641)
64·4%
(56·3 to 73·4)
21·8%
(17·4 to 26·8)
68 903
(60 506 to 78 071)
116 893
(101 592 to 133 368)
69·6%
(60·9 to 78·7)
37·0%
(31·6 to 42·6)
High total cholesterol 2204
(1574 to 3126)
2830
(1966 to 4053)
28·0%
(19·9 to 37·4)
−7·4%
(−11·3 to −2·5)
49 289
(38 075 to 63 764)
62 715
(49 244 to 80 986)
26·9%
(19·8 to 36·3)
−0·6%
(−5·7 to 5·7)
High systolic blood 
pressure
6949
(6182 to 7665)
10 364
(9178 to 11 544)
49·1%
(43·2 to 55·2)
8·8%
(6·4 to 11·2)
143 434
(130 053 to 156 023)
208 129
(188 307 to 227 509)
45·1%
(38·7 to 52·1)
14·1%
(10·0 to 18·4)
High body-mass 
index
2724
(2263 to 3187)
4444
(3716 to 5169)
63·2%
(57·8 to 69·5)
22·2%
(19·0 to 25·4)
78 310
(65 436 to 92 006)
134 048
(112 420 to 156 787)
71·3%
(64·4 to 78·0)
36·3%
(32·3 to 40·1)
Low bone mineral 
density
176
(164 to 198)
334
(285 to 361)
92·1%
(62·8 to 104·0)
35·4%
(15·4 to 44·6)
10 903
(8958 to 13 231)
14 249
(11 658 to 17 500)
30·6%
(20·9 to 40·7)
−1·8%
(−9·4 to 6·9)
Low glomerular 
ﬁ ltration rate
1310
(1176 to 1480)
2164
(1960 to 2387)
65·6%
(54·5 to 74·5)
18·9%
(11·1 to 24·8)
34 159
(30 499 to 38 394)
51 906
(46 246 to 57 573)
52·0%
(43·5 to 59·3)
25·5%
(18·4 to 31·3)
DALYs=disability-adjusted life-years. PAF=population attributable fraction.
Table 3: Global, all-age, all-cause deaths, and DALYs for both sexes combined attributable to each risk factor in 1990 and 2013 with 95% uncertainty intervals
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Figure 8: Global maps for level 3 risk factors in 2013 of attributable DALYs for males (A) and females (B)
DALYs=disability-adjusted life-years. ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. FSM=Federated States of Micronesia. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and 
Tobago. Isl=Islands.
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Particulate matter
Nigeria Childhood undernutrition Unsafe sex Unsafe water Subopt breastfeeding Household air pollution Alcohol use Unsafe sanitation Iron deﬁciency Blood pressure Particulate matter
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Togo Childhood undernutrition Unsafe sex Unsafe water Unsafe sanitation Household air pollution Handwashing Subopt breastfeeding Iron deﬁciency Blood pressure Particulate matter
High systolic blood pressure Blood pressure
Smoking Smoking
High body-mass index Body-mass index
Childhood undernutrition Childhood undernutrition
High fasting plasma glucose Fasting plasma glucose
Alcohol use Alcohol use
Household air pollution from solid fuels Household air pollution
Unsafe water source Unsafe water
Unsafe sex Unsafe sex
Diet low in fruits Fruit
Diet high in sodium Sodium
Ambient particulate matter pollution Particulate matter
High total cholesterol Total cholesterol
Low glomerular ﬁltration rate Glomerular ﬁltration
Diet low in whole grains Whole grains
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Eastern Europe, and central Asia, the leading risk factor 
for both sexes combined was high systolic blood 
pressure, followed by smoking or high BMI. In 
Mongolia, Belarus, and Russia, alcohol was the second 
leading risk factor. Childhood undernutrition remained 
a top ﬁ ve risk in Tajikistan, Turkmenistan, and 
Uzbekistan. In Latin America and the Caribbean, high 
systolic blood pressure or high BMI were the leading 
risks in most countries. Notable exceptions are in Haiti 
and Guatemala, where childhood undernutrition was 
the leading risk. Haiti also stands out with unsafe sex as 
the second leading risk factor. In this region, either high 
fasting plasma glucose or alcohol use were top ﬁ ve risks 
in nearly every country. Unsafe water was a top ﬁ ve risk 
in Haiti and Guatemala. In east Asia, the leading risks 
were high systolic blood pressure, tobacco smoking, and 
high sodium intake. In Oceania, high BMI and high 
fasting plasma glucose were the leading risks in all 
countries, except in Papua New Guinea where smoking 
and childhood undernutrition were most important and 
Vanuatu where high systolic blood pressure was the top 
risk, followed by high BMI. In southeast Asia, high 
systolic blood pressure and smoking were dominant 
risks, except in Laos and Timor-Leste where childhood 
undernutrition was the leading risk. Household air 
pollution was a top ﬁ ve risk in many countries in the 
region. In south Asia, high systolic blood pressure was 
the leading risk, except for in Afghanistan and Pakistan. 
In India, high fasting plasma glucose was the second 
leading risk followed by household air pollution, unsafe 
water, and childhood undernutrition. In North Africa 
and the Middle East, high BMI was the leading risk in 
nearly all countries, and most countries had high fasting 
plasma glucose and high systolic blood pressure as top 
three risks. Sudan and Yemen stand out with childhood 
undernutrition and unsafe water as top three risks. In 
sub-Saharan Africa, there are four patterns: countries 
where the leading risks were childhood undernutrition, 
unsafe water, and unsafe sanitation; countries where the 
leading risks were unsafe sex, childhood undernutrition, 
and unsafe water; countries in southern Africa with 
unsafe sex and alcohol use as leading risks, and island 
nations such as the Seychelles and Cape Verde with high 
systolic blood pressure as leading risk. South Africa is 
notable for the top three risks being unsafe sex, high 
BMI, and alcohol use.
Discussion
Our analysis of 79 risks divided into three broad groups 
of behavioural, environmental and occupational, and 
metabolic risk factors shows that together they explain 
slightly greater than 57% of global deaths and more than 
41% of global DALYs. Each of the risk factors included in 
this analysis is modiﬁ able, pointing to the huge potential 
of prevention to improve human health. Globally, 
behavioural risk factors are the most important followed 
by metabolic and environmental and occupational risk 
factors. This pattern varies substantially: in many 
countries in sub-Saharan Africa, environmental risk 
factors, mainly water, sanitation, no handwashing, and 
household air pollution, are more important than 
metabolic risks. By 2013, the six most important risk 
factors globally were dietary risks, high systolic blood 
pressure, child and maternal malnutrition, tobacco, air 
pollution, and high BMI.
Since 1990, there has been a profound change in risk 
factors associated with the global epidemiological 
transition. In 1990, child and maternal malnutrition and 
unsafe water, sanitation, and handwashing were the 
leading risks for global DALYs, but now these have been 
replaced by dietary risks and high systolic blood pressure. 
A large group of risk factors recorded declines of more 
than 10% in age-standardised PAFs from 1990 to 2013, 
including unsafe water, sanitation, and handwashing; 
household air pollution; suboptimal breastfeeding; 
childhood undernutrition; vitamin A deﬁ ciency; 
secondhand smoke; and diet high in trans fats. By 
contrast, for several risk factors, age-standardised PAFs 
are increasing: intimate partner violence, drug use, high 
BMI, high fasting plasma glucose, low glomerular 
ﬁ ltration rate, unsafe sex, and several components of diet 
(ie, low whole grains, high red meat, and high sugar-
sweetened beverages). This transition in risks reﬂ ects a 
general shift from environmental risks towards 
behavioural and metabolic risks. These insights should 
strengthen our understanding of the epidemiological 
transition and our capacity to forecast population health.
The risk factors included in this study are those that 
met our inclusion criteria. After removing the eﬀ ect of 
these risks, a substantial fraction of global deaths and 
DALYs remain. What might account for the unexplained 
component of death rates and the even greater 
unexplained component for YLDs? Risk-deleted death 
rates (not shown in this paper) vary substantially across 
countries. Other environmental risks, such as soil and 
water contamination, or behavioural risks, such as lack 
of sleep, could explain a component of the unexplained 
variation.53–55 Inclusion of new risk factors in future 
iterations of the GBD might reduce the unattributed 
fraction. Social, economic, and cultural factors could be 
an important part of the explanation, but only the 
components of these risks expressed through diﬀ erential 
behaviours or environmental risks have been 
incorporated in the GBD CRA work so far. Higher 
Figure 9: The ten leading level 3 risks in 2013 in terms of DALYs by location 
for both sexes combined
The 15 leading risk factors are coloured. Subopt=Suboptimal. Occ=occupational. 
DALYs=disability-adjusted life-years. Bone mineral density=low bone mineral 
density. Handwashing=no handwashing with soap. Int partner violence=intimate 
partner violence. Nuts and seeds=diet low in nuts and seeds. Occ 
ergonomic=occupational ergonomic factors. Particulate matter=ambient 
particulate matter pollution. Physical activity=low physical activity. Processed 
meat=diet high in processed meat. Subopt breastfeeding=suboptimal 
breastfeeding. Sweetened beverages=diet high in sugar-sweetened beverages. 
Vegetables=diet low in vegetables.
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risk-deleted age-speciﬁ c death and DALY rates are seen 
in low-income countries and those countries with lower 
educational attainment. Parts of both eﬀ ects would be 
mediated through access to care and coverage with 
curative interventions. From a quarter to half of the 
decline in cardiovascular and circulatory diseases in 
high-income countries have been attributed to 
treatments.56–58 Another aspect of understanding the 
unexplained morbidity is that epidemiological studies 
have studied fewer of, and yielded fewer insights into, 
the drivers of key contributors to YLDs, such as mental 
and substance use disorders, musculoskeletal disorders, 
and neurological disorders. More research on the areas 
we know less about might redress this imbalance.
The behavioural risk factors included in this study 
range from explaining fewer than 19% of DALYs in 2013 
in the Maldives to more than 54% in South Africa. There 
is substantial scope through changing behaviours to 
improve individual and population health. Although 
there is a role for drugs and vaccines to mitigate the 
harmful eﬀ ects of some behaviours, interventions to 
aﬀ ect and change behaviours must be the primary 
mechanisms to reduce this burden. In view of their large 
role, funding for research on interventions to change 
health behaviours by major research funders has been 
scarce. Intellectual property rights are harder to establish 
for behavioural change interventions so there are fewer 
incentives for the private sector to pursue this type of 
investigation. One exception to the absence of private 
sector engagement in this arena is the recent rise of 
personal health mobile device applications. More 
behavioural and social science research into solutions for 
behavioural risks, particularly those that are increasing 
such as the nexus of diet, physical activity, and BMI, is 
urgently needed.
Shifting from the behavioural, environmental and 
occupational, and metabolic risk factors to a more 
comprehensive view of risks including genes, the 
microbiome, public health, and medical care interventions, 
and distal social, economic, and cultural factors, would 
provide a more coherent account of health and its causes. 
The GBD has sought to provide a standardised framework, 
an evidence-based accounting, of the contribution of 
diseases and injuries and selected risks to deaths, YLLs, 
YLDs, and DALYs. It is natural to extend this framework 
progressively to quantify the broader set of risks for health 
outcomes. The rules of evidence, however, used so far in 
the CRA studies might need to be modiﬁ ed to allow this 
expansion. Social, economic, and cultural factors, for 
example, are mediated through several interactive 
pathways in the causal web; we would not expect that 
eﬀ ect sizes would be consistent across contexts. This 
expansion will not be a quick undertaking, but the annual 
revisions of the GBD will provide an opportunity to 
encompass this broadened vision progressively.
The aggregation of the 14 speciﬁ c components of diet 
accounted for nearly one tenth of global DALYs in 2013. 
At the global level, the most important contributors to 
the overall burden of diet are low fruit, high sodium, low 
whole grains, low vegetables, and low nuts and seeds. 
But diet patterns vary greatly across countries and as a 
result the most important diet components vary 
substantially by country. Our diet estimates do not reﬂ ect 
the total eﬀ ect of diet on health. Dietary risk factor 
exposures reﬂ ecting the literature on diet epidemiology 
are standardised to a 2000 calorie diet, resulting in 
dietary exposures that reﬂ ect diet composition rather 
than direct caloric contribution for each risk factor. This 
holds true for all dietary risks except for sugar-sweetened 
beverages, for which the eﬀ ect of calories is captured 
through eﬀ ects on BMI. Other dietary components 
probably aﬀ ect overweight and obesity, in both protective 
and detrimental directions.59,60 If one were to quantify the 
contribution of diet mediated through weight gain and 
BMI, the overall eﬀ ect of diet would be much larger than 
is estimated here. Since GBD 2010, the PREDIMED 
randomised clinical trial reported an eﬀ ect of nut 
consumption that was quite consistent with the estimated 
eﬀ ect from cohort studies.61,62 Yet criticism of dietary 
studies and the eﬀ ects derived from them abounds.63,64 A 
considerable challenge in the diet estimation is that 
component exposures are also likely to be interrelated 
within individuals. There are correlations across 
individuals in the intake of diﬀ erent diet components, 
and there might also be synergistic or antagonistic eﬀ ects 
of dietary components that are consumed together. 
Furthermore, various methods for diet recall all have 
substantial measurement error and biomarkers to 
measure recent diet have not been operationalised to 
date. In view of the importance of diet in this analysis, 
more attention should be paid to quantifying the 
correlation structure of diet components and the eﬀ ects 
of diﬀ erent diet components on weight gain, including 
the eﬀ ect of total caloric intake. Although there are many 
opportunities to improve the estimation of the burden 
attributable to diet, the potential magnitude of the 
beneﬁ ts of shifting to a more optimum diet justify 
concerted examination of policy options to shift 
individual and national diets now.
After diet, high systolic blood pressure is the next most 
important global risk factor accounting for 9·6% of all 
DALYs, up from 5·6% in 1990, making high systolic 
blood pressure larger than ischaemic heart disease and 
three times larger than HIV/AIDS in terms of DALYs. 
Our estimates for DALYs attributable to high systolic 
blood pressure in 2010 are 15% higher than in the 
GBD 2010 analysis for two primary reasons: new 
estimates of the mean blood pressure for each country, 
age, and sex reﬂ ecting new data and an improved model; 
and the shift to use of the lognormal distributional 
assumption, which more closely follows the available 
data. Despite its importance, there has been comparatively 
little global health policy discussion or initiatives focused 
on blood pressure. The WHO voluntary targets for 
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non-communicable diseases have called for a 25% 
reduction in the prevalence of high blood pressure by 
2025. For World Health Day 2013, WHO issued a global 
brief calling for salt reduction and integrated primary 
care management as cost-eﬀ ective routes to address the 
burden of high blood pressure. Although these eﬀ orts 
are welcome, high blood pressure needs a stronger and 
more coherent global response; one that will both 
monitor the burden of high blood pressure and provide 
policy guidance for the most eﬀ ective intervention 
strategies tailored to diﬀ erent contexts.
One key component of diet related to systolic blood 
pressure is high sodium intake; we ﬁ nd that 3·0% of 
global DALYs can be related to sodium intake (95% UI 
1·8–5·3). The wide UI reﬂ ects the uncertainty in the 
sodium TMREL from 1 g to 5 g per day. This widening of 
the TMREL compared with that in GBD 2010 of 1 g 
per day reﬂ ected the growing debate on the optimum 
level of sodium intake. On the one hand, the PURE 
cohort study found a J-shaped association between 
sodium, mortality, and major cardiovascular events 
among 101 945 individuals in 17 countries. On the other 
hand, the J-shaped curve could be due to residual 
confounding or reverse causation. The ﬁ ndings from 
PURE have generated much debate on the methods used 
to measure sodium intake, as well as the potential for low 
sodium intake to reduce blood pressure but raise 
mortality through some aspect of the renin–aldosterone 
system.49,65,66 While the debate on optimum sodium intake 
is likely to continue, even with a much wider TMREL, 
high sodium intake is a major global risk. If the optimum 
sodium intake is 5 g, we still estimate that sodium 
accounts for at least 1·6% of global DALYs, which is more 
than the global DALYs caused by tuberculosis. Voluntary 
and mandatory reductions in sodium content of 
processed foods have been tried and found to be cost 
eﬀ ective in some settings.67,68 Salt substitutes such as 
potassium chloride or blends of sodium and potassium 
chloride are being tested in randomised trials.69,70 Even as 
the science on how far individuals should reduce their 
sodium consumption will continue to evolve, the 
argument for a population-level strategy to reduce 
sodium intake is compelling.
Maternal and child undernutrition was the leading 
global risk in this analysis in 1990 and remains the third 
most important in 2013, causing 6·8% (95% UI 6·2–7·4) 
of global DALYs. This cluster of risks includes in terms of 
importance childhood undernutrition, iron deﬁ ciency, 
suboptimal breastfeeding, vitamin A deﬁ ciency, and zinc 
deﬁ ciency. Compared with the GBD 2010 analysis, this 
cluster of risks is estimated to account for more DALYs 
primarily because for childhood undernutrition we have 
computed the joint distribution of child stunting, 
wasting, and underweight. In the GBD 2010, only child 
underweight was computed. By examining the combined 
eﬀ ects of all three anthropometric measures, we have 
increased the estimated burden by 71%. In sub-Saharan 
Africa, childhood undernutrition remains the leading 
risk factor emphasising the strong link of this risk to 
socioeconomic development; by contrast, in developing 
countries outside sub-Saharan Africa, childhood 
undernutrition has declined profoundly. By estimating 
the combined eﬀ ects of stunting, wasting, and 
underweight, we have documented the enormous 
burden still caused by these risks in the poorest countries. 
The joint estimation, however, is based on back-
calculating the relative risks for stunting, wasting, and 
underweight from published risks that are confounded 
by each other. These estimations will be strengthened by 
pooled analysis of available cohort data that directly 
computes the independent relative risks and their joint 
distribution.
Particulate matter pollution from both ambient sources 
and from household use of solid fuels is a major risk. 
Our estimates for DALYs attributable to ambient 
particulate matter air pollution are slightly lower than 
those in GBD 2010, but our estimates for household air 
pollution are lower by 22% for 2010. The reduction 
reﬂ ects the much larger number of studies used to map 
household fuel use to PM2·5 exposure levels in diﬀ erent 
settings. Regardless of the exact values of these estimates, 
both ambient particulate matter pollution and household 
air pollution are estimated to be major risk factors, 
particularly for non-communicable diseases. These 
environmental risks are classic examples for which 
public policy is required to mitigate risk.71 Because of the 
concave relation between PM2·5 concentration and 
relative risk, the beneﬁ ts of reducing exposure per unit of 
exposure to PM2·5 are greater at lower levels of exposure 
than at higher levels. This beneﬁ t puts a premium on 
reducing exposure down to low levels near the TMREL. 
Both for ambient and household air pollution, the full 
implications of the concave nature of the risk curve need 
to be factored into policy interventions.
Tobacco use remains a major determinant of global 
health, ranking second in terms of risk in 2013, although 
the age-standardised DALY rate has fallen by 32% since 
1990. Although the prevalence of smoking seems to be 
declining or stable in most countries, the burden of 
tobacco suggests that it ought to remain a key focus of 
global health policy debates.20 Continued vigilance is 
absolutely required to ensure that women in developing 
countries, particularly in those with rapidly growing 
economies, do not begin to smoke in large numbers as 
women have done in some high-income countries. 
Equally, the failure of societies to bring down tobacco use 
among men faster than what has been observed over the 
past three to four decades, when the magnitude of the 
hazards had been well established, is of great public 
health concern. The experience of countries such as 
Australia, the UK, and USA, where male smoking 
prevalence has fallen from 70% post war to 15–20% today, 
provides clear evidence that targeted tobacco control 
strategies can work, but are likely to require a 
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combination of strong government commitment, ﬁ scal 
measures, and an informed and active civil society and 
non-governmental organisation sector to advocate 
eﬀ ectively for comprehensive tobacco control 
measures.33,72 Without all of these ingredients, now 
facilitated by WHO’s stewardship and private 
philanthropy driving the MPOWER programme, 
progress will be slow, diﬃ  cult, and at risk of reversals.73,74
Alcohol remains a major risk, ranking sixth among 
level 3 global risk factors, whereas all illicit drug use 
combined ranks 22nd. Yet, although drugs are 
internationally controlled by treaties and a UN agency, 
there is no international public health treaty on alcohol. 
The WHO voluntary targets for non-communicable 
diseases have called for a 10% reduction in the volume of 
alcohol consumption by 2025 where this is nationally 
appropriate, but this is a substantially more modest 
target than those for other leading NCD risk factors, and 
policy initiatives for alcohol are recommended only in 
general terms.75 There is a need for a more coherent and 
eﬀ ective global response, including detailed policy 
guidelines based on the substantial evidence available on 
eﬀ ective intervention strategies.
Our estimates for the burden attributable to high BMI 
are substantially higher than those in GBD 2010 for 
two reasons. First, based on new published pooled cohort 
or meta-analyses, we added several new outcomes related 
to high BMI. Second, we have more accurately captured 
the fraction of the population with high BMI using the 
beta distribution compared with the assumption of a 
normal distribution. There remains some debate in the 
literature on the risks associated with overweight. Flegal 
and colleagues76 reported in a meta-analysis of studies 
reporting on broad categories of BMI that risk is lowest in 
the category of overweight.21 Pooled cohort analysis with 
more detailed BMI categories with a much larger number 
of person-years of exposure found a regular association 
with rising BMI from 23 onwards.77 Part of the discrepancy 
in the ﬁ ndings is also related to how many years of 
observation are excluded from the analysis to remove the 
bias of sick individuals having lowered BMIs. Stokes and 
colleagues showed that re-analysing NHANES follow-up 
data by maximum lifetime BMI suggested that people in 
the overweight category were at substantially elevated risk 
(relative risk 1·28) compared with normal weight 
individuals.78–81 We believe that the balance of the evidence 
clearly supports our TMREL of 21–23 and that the pooled 
cohort studies provide the most robust relative risks 
available to date for this analysis. Regardless of this 
debate, however, the burden attributable to high BMI 
more generally is large and increasing at the global level. 
Intensiﬁ ed research and policy experimentation into the 
options to reduce BMI or to slow its increase is needed.
Our estimates of the burden attributable to unsafe 
water, unsafe sanitation, and no handwashing with soap 
are substantial: 38 countries have more than 5% of DALYs 
attributable to these risks, rising as high as 16% in Chad. 
Redeﬁ ning the risk to be unsafe water and unsafe 
sanitation, and adding in the risk from lack of 
handwashing with soap, increases the burden attributable 
to the cluster of water, sanitation, and hygiene. It also has 
important policy implications: in terms of risk reduction, 
achieving the MDG targets of improved water and 
sanitation would have little eﬀ ect on reducing diarrhoea 
morbidity and mortality. Based on new meta-regressions, 
much of the potential beneﬁ t of water and sanitation is 
through achieving levels of access that are far higher than 
those in the MDG category of improved water or 
sanitation.12 These ﬁ ndings are reﬂ ected in the much 
larger attributable fractions for unsafe water and unsafe 
sanitation as compared with improved water and 
improved sanitation. We believe that future monitoring 
eﬀ orts related to water, sanitation, and hygiene, such as 
those that might emerge from the sustainable 
development goals, should take into account the levels of 
risk associated with diﬀ erent levels of access. Setting the 
goal to be minimum risk, the approach taken here, would 
also mean that many countries, including some middle-
income countries, have a great distance to go. The ﬁ nding 
that no handwashing with soap is a global risk present in 
all regions is a reminder that this nexus of risks is relevant 
to all countries, not just the poorest.
An important aspect of the GBD 2013 has been the 
attempt to estimate the joint counterfactual for metabolic 
risks and all risks together, taking into account mediation 
of some risks through others such as BMI through 
systolic blood pressure. We assume that the fraction 
mediated through another risk is the same across 
countries based on the available literature.52 A more 
precise approach would be to estimate the correlation of 
the risks directly in each population and, through pooled 
studies, analyse the relative risks for the full joint 
distribution of each combination of risks—eg, BMI and 
blood pressure. Administrative data such as electronic 
medical record data might provide a useful database to 
understand the correlation of risks in diﬀ erent 
populations. Use of the average level of mediation noted 
in studies probably means that, at the global level, our 
results are not biased up or down, but in speciﬁ c 
countries our results could be either too high or too low 
for the joint distribution of risks. We propagated the 
uncertainty in the fraction mediated into the ﬁ nal results, 
but this might still underestimate uncertainty because 
we only incorporated the uncertainty in the mean 
estimate of mediation. However, because the joint PAF 
for cardiovascular disease across all risks is so large—
ranging from 63·5% in Chad to 94·3% in Belarus in 
2013—these limitations of the mediation analysis would 
have only a minimum eﬀ ect on the cardiovascular 
disease PAF due to all risk factors. Mediation for other 
major outcomes plays a much smaller part than it does 
for cardiovascular diseases.
In GBD 2010, the integrated exposure–response curve 
for PM2·5 was introduced to take a more uniﬁ ed view of 
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risk exposure across diﬀ erent sources of PM2·5.31,82 The 
crucial assumption is that the PM2·5 is a robust indicator 
of the risk associated with a mixture of pollutants from 
ambient air pollution, tobacco smoking, secondhand 
smoke exposure, and household air pollution exposure to 
PM2·5. This simplifying assumption has received 
substantial attention.83,84 In GBD 2013, we have more 
consistently mapped the outcomes across this set of 
sources of PM2·5: pneumonia has been added as an 
outcome of tobacco smoking, which has been supported 
by tobacco cohort studies.85,86 We have expanded PM2·5 
to cover child and adult lower respiratory infections. In 
view of the crucial importance of the integrated exposure–
response curve to the validity of estimates for household 
air pollution particularly, further research on this is 
required. For household air pollution, one of the crucial 
steps in the analysis is to map from the proxy measure of 
exposure to the level of PM2·5 that is actually 
experienced, to estimate the relative risk from the 
integrated exposure–response curve. In GBD 2010, this 
was mapped using a large study from India and no 
uncertainty in this mapping was incorporated into the 
ﬁ nal results. For GBD 2013, we have based this on 
67 studies from eight regions and have propagated 
uncertainty in this mapping into the ﬁ nal results. The 
net eﬀ ect of these changes has been to widen uncertainty 
and capture regional variation in the level of 
PM2·5 exposure in households using solid fuels.
A major improvement for CRA implemented in the 
GBD 2013 has been the use of exposure distributions 
across individuals that are more consistent with the 
available survey data. The shift from assuming normal 
distributions to lognormal distributions has important 
eﬀ ects on metabolic risks, as does the use of the beta 
distribution for BMI. Fasting plasma glucose has an 
unusual distribution that is not well represented by any 
of the parametric distributions that we tested. In future 
research, it will be important to explore the use of 
alternative methods such as mixture distributions or 
non-parametric approaches. More attention to the 
consistency of the distribution of exposure across 
populations conditional on mean and SD is warranted in 
future cycles of the GBD.
At the global level, the correlation of the number of 
DALYs attributable to the same risks for the year 2010 
across GBD 2010 and GBD 2013 is 0·97. There are several 
notable changes detailed above for risks such as high 
BMI, high systolic blood pressure, and unsafe water, 
sanitation, and handwashing. For other risks there are 
also changes, but, globally, they are generally smaller than 
10% in the year 2010. At the country level, however, there 
are more important changes. The correlation coeﬃ  cient 
for PAFs at the country level is 0·84. These changes can 
be traced to changes in exposure where newer data or 
model revisions have altered the assessments.
The attributable burden of disease formula (equation 1) 
multiplies PAFs by deaths, YLLs, YLDs, or DALYs. All the 
limitations of the estimates of deaths, YLLs, YLDs, and 
DALYs apply to this analysis.18,19 There are, however, 
several important limitations that relate to the 
components of the PAF analysis. First, for most 
outcomes, cohort or randomised controlled trial data are 
available for either mortality or morbidity, but rarely 
both. Second, we apply relative risks from meta-analyses 
or meta-regressions for a disease category such as 
ischaemic heart disease to all the sequelae of that disease, 
but more detailed studies might reveal diﬀ erent relative 
risks. Third, the data representativeness index for some 
risk factors is quite low—eg, handwashing and diet low 
in polyunsaturated fatty acids. Our modelling strategies 
attempt to quantify uncertainty as captured in the 
available data, but it remains possible that new data 
collected in countries without data might reveal levels of 
exposure that are outside the uncertainty intervals that 
we have estimated. Fourth, for unsafe water and unsafe 
sanitation, we assess the availability of infrastructure not 
the use of the infrastructure. Our estimates are not 
biased because the relative risks are derived from similar 
exposure deﬁ nitions. Fifth, some risk factors are 
measured with very coarse proxies for exposure. The 
most extreme example is zinc deﬁ ciency, for which we 
analysed Food and Agriculture Organization of the 
United Nations food balance sheets for absorbable zinc 
and estimated the balance between theoretical intake and 
physiological requirements. Although the proportion of 
people with estimated inadequate zinc intake is a proxy 
of zinc deﬁ ciency, it lacks the anchor to individual level 
measurement of the exposure as a gold standard to 
estimate the number of people at risk. Other examples of 
the use of exposure proxy measurements are the 
proportion of the population in coarse occupational 
categories as a proxy for exposure to speciﬁ c carcinogens, 
and the type of fuel used as a proxy for household air 
pollution. Capturing geographical variation and 
uncertainty in the mapping from household solid fuel 
use to PM2·5 exposure enhances the validity of our 
ﬁ ndings and uncertainty intervals. Nevertheless, more 
direct PM2·5 measurement in households to calibrate 
the more widely available data for fuel use would be 
strongly preferable. Sixth, robust models to estimate 
variation in the SD of risk exposure are harder to develop 
than are estimations of the mean. In many cases, we are 
only able to capture regional variation in the SD. 
Measured SDs from studies are an overestimate of the 
true SDs, because they include the eﬀ ects of 
measurement error. We have not in this study corrected 
SDs for measurement error except for correcting 
observed systolic blood pressure to usual blood pressure.
Seventh, we have not systematically corrected relative 
risks for publication bias. In some cases, there are not 
enough studies to do this. Eighth, relative risks have not 
been corrected for non-masking in studies. For example, 
if the meta-regression of handwashing studies is 
corrected for non-masking, the eﬀ ect size would be 
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non-signiﬁ cant. Many risks, however, cannot be studied 
in a masked fashion, such as tobacco smoking. Correction 
of some risks but not others could introduce worse issues 
of comparability so we have chosen for this study to not 
correct for non-masking in study design.
Ninth, with few exceptions, we assume that relative 
risks are universal across countries for a given age–sex 
group with few exceptions.45,46 Some studies have argued 
that the BMI relative risk curve and TMREL might vary 
geographically, but there was insuﬃ  cient evidence to date 
to identify statistically signiﬁ cant diﬀ erences in relative 
risks, except in the case of breast cancer. Generally, as 
further evidence accumulates, we might ﬁ nd more 
examples of non-universal relative risks. We have not 
incorporated into our uncertainty intervals any qualitative 
assessment of the potential for non-universal risks.
Tenth, some heterogeneity remains around the 
implementation of the TMREL concept. For example, for 
exposure to ambient particulate matter pollution, the 
TMREL has been chosen as between 5·9 μg/m³ and 
8·7 μg/m³, but zero PM2·5 arguably might be the lowest 
risk. Cohort data to support the notion that the relative 
risk continues to decline below 5·8 μg/m³, however, are 
limited. Eleventh, for unsafe sex, HIV risk from injecting 
drug use, and occupational injuries, we have not used the 
relative risk and exposure PAF calculation. Attributable 
fractions of HIV for unsafe sex and injecting drug use 
have been based on direct evidence of the attributable 
fraction. These direct or categorical approaches might not 
yield results that are strictly comparable to the risks 
estimated with the relative risk and exposure model.
Twelfth, for risk factors for which we do not correct for 
mediation, we assume their joint eﬀ ect can be estimated 
with the multiplicative risk model. This model, while 
plausible, might not accurately capture how all risks 
interact. Unfortunately, there are no cohort studies 
available of suﬃ  cient size to study the nature of these 
interactions in more detail. Thirteenth, the fraction of a 
risk factor mediated through another risk factor might be 
underestimated because of measurement error in both 
risk factors (similar to the case of regression dilution bias 
due to the exposure measurement error).28
Fourteenth, for air pollution, there are few studies that 
allow estimation of the quantitative contribution of 
household air pollution to ambient air pollution or vice 
versa.87 As such we might have underestimated the 
burden of household air pollution as a single risk factor; 
we might also have overestimated the burden of air 
pollution combined. Lastly, estimating burden for risks 
divided into polytomous risks might underestimate their 
burden compared with estimating burden with a 
continuous risk variable.
Strategies and policies to improve the health of 
populations should be guided by the comparative 
importance of health loss arising from exposure to major 
risk factors, whatever their position in the causal chain. It 
is the underlying causes of diseases and injuries that 
ought to guide prevention eﬀ orts, and knowing their 
comparative magnitude and trends in causing health loss 
is arguably among the most important information 
required by countries to prioritise health programmes and 
policies. The comprehensive assessment of risk factors 
presented in this study provides a clear indication of 
where prevention programmes aimed at risk factor 
modiﬁ cation can have major eﬀ ects on health. The 
challenge for governments and the health development 
community more broadly is to heed this knowledge about 
the comparative eﬀ ect of health risks more assiduously, 
and orient health policies towards their mitigation with 
much greater conviction than that currently observed. Yet 
our ﬁ ndings that the list of risk factor–outcome pairs that 
meet the bar of convincing or probable evidence account 
for slightly less than 40% of the entire GBD strongly 
suggest that massive health gains could be expected from 
adoption of policies to avoid what is avoidable. Certainly, 
there are more risk factors yet to be discovered and some 
well known risks such as poverty and education have not 
yet been quantiﬁ ed according to this framework. But such 
unknowns should not impede a much greater response 
from countries and donors to implement policies that are 
known to work in controlling diseases and injuries, and 
which have demonstrably led to much improved health 
outcomes in countries that have adopted them.
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